FRED HUTCHINSON CANCER RESEARCH CENTER: Form 990, tax year 2010

View the entire original 990 at ProPublica ↗

Organization: FRED HUTCHINSON CANCER RESEARCH CENTER (EIN 23-7156071)
Tax period: 2010-07-01 to 2011-06-30
Filed: 2012-05-14
IRS object ID: 201221359349306477
Schema version: 2010v3.4
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule K
Schedule K
Schedule K
Schedule K
Schedule L
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Timestamp	2012-05-14T17:27:30-07:00	Timestamp
Tax Period End Date	2011-06-30	TaxPeriodEndDate
Return Type	990	ReturnType
Tax Period Begin Date	2010-07-01	TaxPeriodBeginDate

Filer Filer

Field	Value	IRS element (for citing)
EIN	237156071	EIN

Name Name

Field	Value	IRS element (for citing)
Business Name Line1	FRED HUTCHINSON CANCER RESEARCH CENTER	BusinessNameLine1

Field	Value	IRS element (for citing)
Name Control	FRED	NameControl
Phone	2066674876	Phone

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1100 Fairview Avenue North	AddressLine1
City	Seattle	City
State	WA	State
ZIP Code	981091024	ZIPCode

Officer Officer

Field	Value	IRS element (for citing)
Name	RANDALL C MAIN	Name
Title	VICE PRESIDENT AND CFO	Title
Phone	2066674876	Phone
Date Signed	2012-05-14	DateSigned

Field	Value	IRS element (for citing)
Tax Year	2010	TaxYear
Build TS	2016-02-24 21:20:13Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Name Of Principal Officer Person	Lawrence Corey	NameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

Field	Value	IRS element (for citing)
Address Line1	1100 Fairview Ave North	AddressLine1
City	Seattle	City
State	WA	State
ZIP Code	98109	ZIPCode

Field	Value	IRS element (for citing)
Gross Receipts	567226626	GrossReceipts
Group Return For Affiliates	0	GroupReturnForAffiliates
Organization501c3	X	Organization501c3
Web Site	www.fhcrc.org	WebSite
Type Of Organization Corporation	X	TypeOfOrganizationCorporation
Year Formation	1971	YearFormation
State Legal Domicile	WA	StateLegalDomicile
Activity Or Mission Description	The mission of the Fred Hutchinson Cancer Research Center is the elimination of cancer and related diseases as causes of human suffering and death. The Center conducts research of the highest standards to improve prevention and treatment of cancer and related diseases.	ActivityOrMissionDescription
Nbr Voting Members Governing Body	20	NbrVotingMembersGoverningBody
Nbr Independent Voting Members	19	NbrIndependentVotingMembers
Total Nbr Employees	3117	TotalNbrEmployees
Total Nbr Volunteers	400	TotalNbrVolunteers
Total Gross UBI	-85743	TotalGrossUBI
Net Unrelated Business Txbl Income	-85743	NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year	345330959	ContributionsGrantsPriorYear
Contributions Grants Current Year	388454000	ContributionsGrantsCurrentYear
Program Service Revenue Prior Year	44856905	ProgramServiceRevenuePriorYear
Program Service Revenue CY	51692311	ProgramServiceRevenueCY
Investment Income Prior Year	4541566	InvestmentIncomePriorYear
Investment Income Current Year	9756524	InvestmentIncomeCurrentYear
Other Revenue Prior Year	12787637	OtherRevenuePriorYear
Other Revenue Current Year	20703489	OtherRevenueCurrentYear
Total Revenue Prior Year	407517067	TotalRevenuePriorYear
Total Revenue Current Year	470606324	TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year	62506551	GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY	80189368	GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year	0	BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY	0	BenefitsPaidToMembersCY
Salaries Etc Prior Year	205262594	SalariesEtcPriorYear
Salaries Etc Current Year	214220175	SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year	88717	TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY	59204	TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year	5599404	TotalFundrsngExpCurrentYear
Other Expense Prior Year	120781361	OtherExpensePriorYear
Other Expenses Current Year	131738614	OtherExpensesCurrentYear
Total Expenses Prior Year	388639223	TotalExpensesPriorYear
Total Expenses Current Year	426207361	TotalExpensesCurrentYear
Revenues Less Expenses Prior Year	18877844	RevenuesLessExpensesPriorYear
Revenues Less Expenses CY	44398963	RevenuesLessExpensesCY
Total Assets BOY	555798313	TotalAssetsBOY
Total Assets EOY	714148481	TotalAssetsEOY
Total Liabilities BOY	362793049	TotalLiabilitiesBOY
Total Liabilities EOY	461116144	TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY	193005264	NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY	253032337	NetAssetsOrFundBalancesEOY
Mission Description	The mission of the Fred Hutchinson Cancer Research Center is the elimination of cancer and related diseases as causes of human suffering and death. The Center conducts research of the highest standards to improve prevention and treatment of cancer and related diseases.	MissionDescription
Significant New Program Services	0	SignificantNewProgramServices
Significant Change	0	SignificantChange
Expense	97970042	Expense
Grants	17845852	Grants
Revenue	4115055	Revenue
Description	Program Overview: The Center performs fundamental research in clinical, basic and population science disciplines; exhibits a special competence as a designated research center; serves as a focal point for testing and evaluating outputs of research and development efforts; and couples the outputs of cancer research efforts with medical practice. The Center performs these functions through its five scientific research divisions: Public Health Sciences, Clinical Research, Basic Sciences, Human Biology and Vaccine and Infectious Disease. Public Health Sciences ("PHS") The Division of Public Health Sciences' mission is to identify strategies that will ultimately reduce the incidence of and mortality from cancer and other diseases. PHS faculty focus on determining causes of cancer, helping to identify and assess effective screening and treatment methods, developing prevention strategies that reduce the risk of cancer, and developing research strategies to assist people to change behaviors toward healthier lifestyles. This prevention-oriented research also extends to other diseases, including HIV/AIDS, cardiovascular disease, diabetes, and fractures. The Division of Public Health Sciences is home to the nation's oldest and largest program devoted to cancer-prevention research-an important endeavor, considering that many cancers may be avoidable by changes in lifestyle. The PHS Division is organized into six administrative programs. Each of these programs has a faculty with a wide range of interests and an interactive and interdisciplinary research orientation. These programs are as follows: Biostatistics and Biomathematics - The Biostatistics & Biomathematics Program provides statistical collaboration and coordination for research programs within and outside the center, develops and evaluates new quantitative methods for the efficient design and analysis of a broad range of biomedical studies and constructs biomathematical models of carcinogenesis and other biological processes. Cancer Biology - The Cancer Biology Program applies molecular biology, genetics, pathology, epidemiology, and biostatistics to studies of human populations, focusing on the root causes of cancer. Cancer Prevention - The Cancer Prevention Program uses interdisciplinary approaches to evaluate the causes, detection and control of cancer in laboratory, clinic and community-based studies. Computational Biology - Scientists within the Computational Biology Program use and develop computational methods and tools to address biological questions. The Program encompasses a wide range of bioinformatic and computational approaches. Epidemiology - The Epidemiology Program seeks to determine the causes of cancers through studies in human populations of personal exposures, behavioral characteristics, and genes that may influence a person's chances of developing one or more cancers. Molecular Diagnostics - The Molecular Diagnostics Program works to discover accurate methods for determining an individual's cancer risk; detecting cancer at its earliest, most curable stage; classifying the type and extent of cancer, once diagnosed; and monitoring response to therapy and disease progression.	Description

Activity2 Activity2

Field	Value	IRS element (for citing)
Expense	86645261	Expense
Grants	8886306	Grants
Revenue	13263449	Revenue
Description	Clinical Research Division: From laboratory bench to bedside, the Clinical Research Division works to develop and analyze new treatments for cancers and other diseases. Researchers seek new or improved ways to cure cancer. Foremost among their contributions has been the development of bone marrow transplantation, a technique that is now saving tens of thousands of lives worldwide annually. In 1990, Dr. E. Donnall Thomas, director emeritus of the Clinical Research Division, received the Nobel Prize in physiology or medicine for his pioneering work developing this technique. Through clinical research, Center scientists continue to refine the techniques of transplantation and extend its use. Once exclusively used for treatment of leukemia, lymphomas and similar diseases, bone marrow transplantation is now being successfully applied to a growing number of diseases, including breast, ovarian and kidney cancer, sickle cell disease and autoimmune disorders such as multiple sclerosis and scleroderma. Other avenues of research being conducted in the Clinical Research Division include immunotherapy, antibody therapy and cancer vaccines. Approximately 450 patients from all over the world receive transplants at the Seattle Cancer Care Alliance coordinated by researchers from the Center's Bone Marrow Transplant Program. The Seattle Cancer Care Alliance, established in 1998, unites the adult and pediatric cancer-care services of the Hutchinson Center, UW Medicine and Seattle Children's. A major focus of SCCA is to speed the transfer of new diagnostic and treatment techniques from the research setting to the patient bedside while providing premier, patient-focused cancer care. Thousands of other cancer patients will be able to receive similar treatment in their local hospitals as a result of the knowledge shared by Clinical Research Division scientists with physicians around the world. Because of the Center's training efforts, many hospitals throughout the United States now perform bone marrow transplants. Scientists in the Center's Clinical Research Division have recorded several "firsts" in cancer research and treatment: * Showing that patients with acute leukemia who have failed chemotherapy can be cured with bone marrow transplantation. * Showing that bone marrow transplantation is the best form of initial therapy for patients with acute myelogenous leukemia, a disease that affects approximately 15,000 Americans each year. * Showing that bone marrow transplantation can cure chronic myelogenous leukemia, a disease that is otherwise incurable and affects approximately 3,000 Americans each year. * Developing the first FDA-approved antibody-targeted chemotherapy, making chemotherapy less toxic and more effective. * Pioneering the first antibody-targeted therapy against a marker specific to non-Hodgkins lymphoma, an approach now used to treat thousands of people each year. * Developing a "tumor paint" that will help surgeons see where a tumor begins and ends more precisely by illuminating the cancerous cells. The tumor paint, derived from scorpion venom, was developed in collaboration with researchers at Seattle Children's Hospital Research Institute. The high quality of the research conducted in the Center's Clinical Research Division is matched only by the quality of care provided to patients receiving treatment.	Description

Activity3 Activity3

Field	Value	IRS element (for citing)
Expense	120336383	Expense
Grants	43937224	Grants
Revenue	5054513	Revenue
Description	Vaccine and Infectious Disease Division ("VIDD") The Vaccine and Infectious Disease Division (VIDD) scientists integrate clinical care, computational methods and basic science research to reduce the global burden of infectious disease. VIDD has over 50 faculty members who specialize in a range of disciplines that synergize and complement one another. Administratively, VIDD also encompasses major networks and service programs as well as clinical consulting services in infectious diseases. The multidisciplinary nature of VIDD's faculty and services provide a robust and cohesive scientific community. VIDD research programs integrate the latest in computational, laboratory and clinical research methods to advance the understanding of microbial pathogenesis and infectious disease processes. VIDD researchers partner with scientists at laboratory, clinical and field sites in Africa, Asia and Europe. The Division has specific initiatives in Uganda, China and the Republic of South Africa to advance the understanding of infection-related cancers and infectious diseases that affect high-risk populations in these regions. VIDD scientists around the world including clinicians, clinical trials specialists, statisticians, computational biologists and basic scientists take pride in their collaborative efforts to predict, detect, treat and prevent infectious diseases in humans.	Description

Activity Other ActivityOther

Field	Value	IRS element (for citing)
Expense	97769315	Expense
Grants	9519986	Grants
Revenue	29259294	Revenue
Description	(Expenses $97,769,315 including grants of $9,519,986) (Revenue $29,259,294)	Description

Field	Value	IRS element (for citing)
Total Of Other Program Service Exp	97769315	TotalOfOtherProgramServiceExp
Total Of Other Program Service Grnt	9519986	TotalOfOtherProgramServiceGrnt
Total Of Other Program Service Rev	29259294	TotalOfOtherProgramServiceRev
Total Program Service Expense	402721001	TotalProgramServiceExpense
Described In501 C3	1	DescribedIn501C3
Schedule B Required	1	ScheduleBRequired
Political Activities	0	PoliticalActivities
Lobbying Activities	1	LobbyingActivities
Subject To Proxy Tax	0	SubjectToProxyTax
Donor Advised Funds	0	DonorAdvisedFunds
Conservation Easements	0	ConservationEasements
Collections Of Art	1	CollectionsOfArt
Credit Counseling	0	CreditCounseling
Term Or Permanent Endowments	1	TermOrPermanentEndowments
Report Land Bldg Equip	1	ReportLandBldgEquip
Report Invest Oth Securities	1	ReportInvestOthSecurities
Report Prog Rel Invest	1	ReportProgRelInvest
Report Other Assets	0	ReportOtherAssets
Report Other Liabilities	1	ReportOtherLiabilities
Report Fin48 Footnote	0	ReportFin48Footnote
Independent Audit Financial Stmt	1	IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt	0	ConsolidatedAuditFinancialStmt
School	0	School
Foreign Office	0	ForeignOffice
Foreign Activities	1	ForeignActivities
More Than5000 K To Organizations	1	MoreThan5000KToOrganizations
More Than5000 K To Individuals	1	MoreThan5000KToIndividuals
Professional Fundraising	1	ProfessionalFundraising
Fundraising Activities	1	FundraisingActivities
Gaming	0	Gaming
Hospital	0	Hospital
Grants To Organizations	1	GrantsToOrganizations
Grants To Individuals	0	GrantsToIndividuals
Schedule J Required	1	ScheduleJRequired
Tax Exempt Bonds	1	TaxExemptBonds
Invest Tax Exempt Bonds	0	InvestTaxExemptBonds
Escrow Account	1	EscrowAccount
On Behalf Of Issuer	0	OnBehalfOfIssuer
Excess Benefit Transaction	0	ExcessBenefitTransaction
Prior Excess Benefit Transaction	0	PriorExcessBenefitTransaction
Loan To Officer Or DQP	0	LoanToOfficerOrDQP
Grant To Related Person	0	GrantToRelatedPerson
Bsnss Rltnshp With Organization	0	BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member	1	BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp	1	OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions	1	DeductibleNonCashContributions
Deductible Contributions Of Art	0	DeductibleContributionsOfArt
Terminated	0	Terminated
Partial Liquidation	0	PartialLiquidation
Disregarded Entity	0	DisregardedEntity
Related Entity	1	RelatedEntity
Related Org Controlled Entity	1	RelatedOrgControlledEntity
Transaction Related Entity	1	TransactionRelatedEntity
Transfers To Exempt Non Chrtbl Org	0	TransfersToExemptNonChrtblOrg
Activities Conducted Partnership	0	ActivitiesConductedPartnership
Schedule O Required	1	ScheduleORequired
Number Forms Transmitted With1096	0	NumberFormsTransmittedWith1096
Number W2 G Included	0	NumberW2GIncluded
Number Of Employees	3117	NumberOfEmployees
Employment Tax Returns Filed	1	EmploymentTaxReturnsFiled
Unrelated Business Income	1	UnrelatedBusinessIncome
Form990-T Filed	1	Form990-TFiled
Foreign Financial Account	1	ForeignFinancialAccount
Name Of Foreign Country	CJ	NameOfForeignCountry
Name Of Foreign Country	UK	NameOfForeignCountry
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTrans
Taxable Party Notification	0	TaxablePartyNotification
Non Deductible Contributions	0	NonDeductibleContributions
Quid Pro Quo Contributions	1	QuidProQuoContributions
Quid Pro Quo Disclosure	1	QuidProQuoDisclosure
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOf
Funds To Pay Premiums	0	FundsToPayPremiums
Premiums Paid	0	PremiumsPaid
Form1098 C Filed	0	Form1098CFiled
Indoor Tanning Services	0	IndoorTanningServices
Info In Schedule O Part VI	X	InfoInScheduleOPartVI
Nbr Voting Governing Body Members	20	NbrVotingGoverningBodyMembers
Number Independent Voting Members	19	NumberIndependentVotingMembers
Family Or Business Relationship	0	FamilyOrBusinessRelationship
Delegation Of Management Duties	0	DelegationOfManagementDuties
Changes To Organizing Docs	0	ChangesToOrganizingDocs
Material Diversion Or Misuse	0	MaterialDiversionOrMisuse
Members Or Stockholders	0	MembersOrStockholders
Election Of Board Members	0	ElectionOfBoardMembers
Decisions Subject To Approval	0	DecisionsSubjectToApproval
Minutes Of Governing Body	1	MinutesOfGoverningBody
Minutes Of Committees	1	MinutesOfCommittees
Officer Mailing Address	0	OfficerMailingAddress
Local Chapters	1	LocalChapters
Policies Reference Chapters	1	PoliciesReferenceChapters
Form990 Provided To Governing Body	1	Form990ProvidedToGoverningBody
Conflict Of Interest Policy	1	ConflictOfInterestPolicy
Annual Disclosure Covered Persons	1	AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement	1	RegularMonitoringEnforcement
Whistleblower Policy	1	WhistleblowerPolicy
Document Retention Policy	1	DocumentRetentionPolicy
Compensation Process CEO	1	CompensationProcessCEO
Compensation Process Other	1	CompensationProcessOther
Investment In Joint Venture	0	InvestmentInJointVenture
States Where Copy Of Return Is Filed	AK	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AR	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AZ	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CO	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CT	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	FL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	GA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	HI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	IL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	KS	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	KY	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MD	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	ME	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MN	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MO	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MS	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NC	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	ND	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NH	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NJ	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NM	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NY	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OH	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OK	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OR	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	PA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	RI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	SC	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	TN	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	UT	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	VA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WV	StatesWhereCopyOfReturnIsFiled
Upon Request	X	UponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

Field	Value	IRS element (for citing)
Business Name Line1	Fred Hutchinson Cancer Research Center	BusinessNameLine1
Business Name Line2	Randy Main	BusinessNameLine2

Field	Value	IRS element (for citing)
Telephone Number	2066674876	TelephoneNumber

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	1100 Fairview Ave North	AddressLine1
Address Line2	J6-300	AddressLine2
City	Seattle	City
State	WA	State
ZIP Code	98109	ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (46 entries)

TitleTitle	Average Hours Per WeekAverageHoursPerWeek	Individual Trustee Or DirectorIndividualTrusteeOrDirector	Reportable Comp From OrganizationReportableCompFromOrganization	Reportable Comp From Related OrgsReportableCompFromRelatedOrgs	Other CompensationOtherCompensation	OfficerOfficer	Key EmployeeKeyEmployee	Highest Compensated EmployeeHighestCompensatedEmployee	FormerFormer
Douglas Walker
Trustee, Chair	5	X	0	0	0
Steve Davis
Trustee, Vice Chair	5	X	0	0	0
Richard Anderson
Trustee	2	X	0	0	0
Hollis Dillon
Trustee	2	X	0	0	0
Karl Ege
Treasurer	6	X	0	0	0
Karen Glover
Trustee	3	X	0	0	0
Ronald Howell
Trustee	2	X	0	0	0
Peter Horvitz
Trustee	1	X	0	0	0
Don Listwin
Trustee	1	X	0	0	0
Richard McCune
Trustee	1	X	0	0	0
Karen Moyer
Trustee	1	X	0	0	0
Sally Narodick
Trustee, Immediate Past Chair	2	X	0	0	0
Robert Nelson
Trustee	1	X	0	0	0
Peter Neupert
Trustee	1	X	0	0	0
Charles Nolan
Trustee	1	X	0	0	0
James Sinegal
Trustee	2	X	0	0	0
Stephen Sundborg
Trustee	1	X	0	0	0
Vijay Vashee
Trustee	2	X	0	0	0
Douglas Williams
Trustee, Secretary	2	X	0	0	0
Stephen Graham
Trustee	2	X	0	0	0
Lawrence Corey
President & Director (Effective 1/1/2011)	9		125802	0	0	X
Leland H Hartwell
President & Director	40		592890	0	41293	X
Frederick R Appelbaum
Sr VP & Dir, Clin Res Div	40		588354	0	43686	X
Janell E Baldwin
VP Shared Resources	40		202337	0	32522	X
Anthony Bozzuti
VP & Chief Information Officer	40		255756	0	16074	X
Jonathan Cooper
Sr VP & Dir, Basic Sci	40		262763	0	38493	X
Linda L Gainer
VP External Affairs & Comm	40		246720	0	43292	X
Mark T Groudine
Sr VP & Deputy Dir, FHCRC	40		468180	0	61056	X
Randall C Main
VP & Chief Financial Officer	40		368324	0	44556	X
Margaret Juliana McElrath
Sr VP & Co-Dir, VIDD	40		232458	0	59191	X
Ulrich W Mueller
VP Industry Rel & Tech Transfer	40		252869	0	47322	X
Howard Albert Nachtrieb
VP Human Resources	40		242965	0	47250	X
Ross L Prentice
Sr VP & Dir, PHS	40		399255	0	44538	X
Scott N Rusch
VP Operations & Facilities	40		201776	0	38218	X
Douglas J Shaeffer
VP General Counsel	40		319538	0	44807	X
Myra H Tanita
Exec VP & COO	40		473212	0	45780	X
Barbara Trask
Sr VP & Dir, Human Biology	40		284882	0	56778	X
Steven G Self
Co-Dir, VIDD	40		281222	0	67642		X
Irwin D Bernstein
Full Member	40		295080	0	59165			X
Martin A Cheever
Full Member	40		288162	0	56695			X
Samir M Hanash
Full Member	40		328794	0	43254			X
Charles N Petty
Staff Physician	40		262694	0	36995			X
Henry F Warden
Executive Director, VIDD	40		261812	0	39064			X
F Marc Stewart
Medical Director, SCCA	40		197371	0	37179				X
Rainier F Storb
Full Member	40		247218	0	57436				X
James M Roberts
Full Member	40		148155	0	35145				X

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	7828589	TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs	0	TotalReportableCompFrmRltdOrgs
Total Other Compensation	1137431	TotalOtherCompensation
Number Individuals GT100 K	318	NumberIndividualsGT100K
Formers Listed	1	FormersListed
Total Comp GT150 K	1	TotalCompGT150K
Compensation From Other Sources	0	CompensationFromOtherSources

Contractor Compensation ContractorCompensation (5 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1	CityAddressOfContractor/AddressUS/City	StateAddressOfContractor/AddressUS/State	ZIP CodeAddressOfContractor/AddressUS/ZIPCode	Description Of ServicesDescriptionOfServices	CompensationCompensation
Seattle Cancer Care Alliance
825 Eastlake Ave E	Seattle	WA	98109	Patient care services	3520670
Metropolitan Building Maintenance Co
3829 Aurora Ave N	Seattle	WA	98103	Maintenance services	1319794
JP Morgan Chase Bank NA
1111 Polaris Parkway	Columbus	OH	43240	Letter of Credit fees	1155929
McKinsey and Company Inc
55 E 52nd St	New York	NY	10022	Consulting services	1134900
Bank of America
401 N Tryon St	Charlotte	NC	28255	Letter of Credit fees	1060776

Field	Value	IRS element (for citing)
Number Of Contractors GT100 K	48	NumberOfContractorsGT100K
Federated Campaigns	658821	FederatedCampaigns
Membership Dues	0	MembershipDues
Fundraising Events	7416286	FundraisingEvents
Related Organizations	0	RelatedOrganizations
Government Grants	319314618	GovernmentGrants
All Other Contributions	61064275	AllOtherContributions
Noncash Contributions	6442158	NoncashContributions
Total Contributions	388454000	TotalContributions

Program Service Revenue ProgramServiceRevenue (3 entries)

DescriptionDescription	Business CodeBusinessCode	Total Revenue ColumnTotalRevenueColumn	Related Or Exempt Function IncomeRelatedOrExemptFunctionIncome	ExclusionExclusionAmount
Research Activities	900099	12808946	12808946	$0
Interaffiliate Agreements & Services	900099	29259294	29259294	$0
Patient Services at SCCA	900099	9624071	9624071	$0

Total Oth Program Service Revenue TotalOthProgramServiceRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	0	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	$0	ExclusionAmount

Field	Value	IRS element (for citing)
Total Program Service Revenue	51692311	TotalProgramServiceRevenue

Investment Income InvestmentIncome

Field	Value	IRS element (for citing)
Total Revenue Column	3266921	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	-85743	UnrelatedBusinessRevenue
Exclusion	$3,352,664	ExclusionAmount

Income From Invest Bond Proceeds IncomeFromInvestBondProceeds

Field	Value	IRS element (for citing)
Total Revenue Column	202743	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	$202,743	ExclusionAmount

Royalties Revenue RoyaltiesRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	18424245	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	$18,424,245	ExclusionAmount

Gross Rents GrossRents

Field	Value	IRS element (for citing)
Real	2738491	Real
Personal	0	Personal

Less Rental Expenses LessRentalExpenses

Field	Value	IRS element (for citing)
Real	0	Real
Personal	0	Personal

Rental Income Or Loss RentalIncomeOrLoss

Field	Value	IRS element (for citing)
Real	2738491	Real
Personal	0	Personal

Net Rental Income Or Loss NetRentalIncomeOrLoss

Field	Value	IRS element (for citing)
Total Revenue Column	2738491	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	$2,738,491	ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

Field	Value	IRS element (for citing)
Securities	101879000	Securities
Other	48250	Other

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

Field	Value	IRS element (for citing)
Securities	95640390	Securities
Other	0	Other

Gain Or Loss GainOrLoss

Field	Value	IRS element (for citing)
Securities	6238610	Securities
Other	48250	Other

Net Gain Or Loss Investments NetGainOrLossInvestments

Field	Value	IRS element (for citing)
Total Revenue Column	6286860	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	$6,286,860	ExclusionAmount

Field	Value	IRS element (for citing)
Gross Income Fundraising Events	520665	GrossIncomeFundraisingEvents
Cntrbtns Rprtd Fundraising Events	7416286	CntrbtnsRprtdFundraisingEvents
Fundraising Direct Expenses	979912	FundraisingDirectExpenses

Net Income From Fundraising Events NetIncomeFromFundraisingEvents

Field	Value	IRS element (for citing)
Total Revenue Column	-459247	TotalRevenueColumn
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	-$459,247	ExclusionAmount

Field	Value	IRS element (for citing)
Gross Income Gaming	0	GrossIncomeGaming
Gaming Direct Expenses	0	GamingDirectExpenses

Net Income From Gaming NetIncomeFromGaming

Field	Value	IRS element (for citing)
Total Revenue Column	0	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	$0	ExclusionAmount

Field	Value	IRS element (for citing)
Gross Sales Of Inventory	0	GrossSalesOfInventory
Cost Of Goods Sold	0	CostOfGoodsSold

Net Income Or Loss NetIncomeOrLoss

Field	Value	IRS element (for citing)
Total Revenue Column	0	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	$0	ExclusionAmount

Field	Value	IRS element (for citing)
Total Other Revenue	0	TotalOtherRevenue

Total Revenue TotalRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	470606324	TotalRevenueColumn
Related Or Exempt Function Income	51692311	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	-85743	UnrelatedBusinessRevenue
Exclusion	$30,545,756	ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

Field	Value	IRS element (for citing)
Total	73784560	Total
Program Services	73784560	ProgramServices

Grants To Domestic Individuals GrantsToDomesticIndividuals

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices

Foreign Grants ForeignGrants

Field	Value	IRS element (for citing)
Total	6404808	Total
Program Services	6404808	ProgramServices

Benefits To Members BenefitsToMembers

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices

Comp Current Officers Directors CompCurrentOfficersDirectors

Field	Value	IRS element (for citing)
Total	6653495	Total
Program Services	3467460	ProgramServices
Management And General	3186035	ManagementAndGeneral
Fundraising	0	Fundraising

Comp Disqual Persons CompDisqualPersons

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices
Management And General	0	ManagementAndGeneral
Fundraising	0	Fundraising

Other Salaries And Wages OtherSalariesAndWages

Field	Value	IRS element (for citing)
Total	164643143	Total
Program Services	134035564	ProgramServices
Management And General	27477701	ManagementAndGeneral
Fundraising	3129878	Fundraising

Pension Plan Contributions PensionPlanContributions

Field	Value	IRS element (for citing)
Total	11199185	Total
Program Services	9187601	ProgramServices
Management And General	1805412	ManagementAndGeneral
Fundraising	206172	Fundraising

Other Employee Benefits OtherEmployeeBenefits

Field	Value	IRS element (for citing)
Total	19799988	Total
Program Services	16161394	ProgramServices
Management And General	3278870	ManagementAndGeneral
Fundraising	359724	Fundraising

Payroll Taxes PayrollTaxes

Field	Value	IRS element (for citing)
Total	11924364	Total
Program Services	9608576	ProgramServices
Management And General	2105449	ManagementAndGeneral
Fundraising	210339	Fundraising

Fees For Services Management FeesForServicesManagement

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices
Management And General	0	ManagementAndGeneral
Fundraising	0	Fundraising

Fees For Services Legal FeesForServicesLegal

Field	Value	IRS element (for citing)
Total	1513271	Total
Program Services	7012	ProgramServices
Management And General	1506259	ManagementAndGeneral
Fundraising	0	Fundraising

Fees For Services Accounting FeesForServicesAccounting

Field	Value	IRS element (for citing)
Total	257995	Total
Program Services	0	ProgramServices
Management And General	257995	ManagementAndGeneral
Fundraising	0	Fundraising

Fees For Services Lobbying FeesForServicesLobbying

Field	Value	IRS element (for citing)
Total	118859	Total
Program Services	0	ProgramServices
Management And General	118859	ManagementAndGeneral
Fundraising	0	Fundraising

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	59204	Total
Fundraising	59204	Fundraising

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

Field	Value	IRS element (for citing)
Total	1032945	Total
Program Services	0	ProgramServices
Management And General	1032945	ManagementAndGeneral
Fundraising	0	Fundraising

Fees For Services Other FeesForServicesOther

Field	Value	IRS element (for citing)
Total	22522933	Total
Program Services	11939125	ProgramServices
Management And General	10189026	ManagementAndGeneral
Fundraising	394782	Fundraising

Advertising Advertising

Field	Value	IRS element (for citing)
Total	392762	Total
Program Services	0	ProgramServices
Management And General	323827	ManagementAndGeneral
Fundraising	68935	Fundraising

Office Expenses OfficeExpenses

Field	Value	IRS element (for citing)
Total	4176956	Total
Program Services	1042828	ProgramServices
Management And General	2563387	ManagementAndGeneral
Fundraising	570741	Fundraising

Information Technology InformationTechnology

Field	Value	IRS element (for citing)
Total	1044952	Total
Program Services	0	ProgramServices
Management And General	1044952	ManagementAndGeneral
Fundraising	0	Fundraising

Royalties Royalties

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices
Management And General	0	ManagementAndGeneral
Fundraising	0	Fundraising

Occupancy Occupancy

Field	Value	IRS element (for citing)
Total	6882880	Total
Program Services	117312	ProgramServices
Management And General	6765568	ManagementAndGeneral
Fundraising	0	Fundraising

Travel Travel

Field	Value	IRS element (for citing)
Total	2592397	Total
Program Services	2151648	ProgramServices
Management And General	319382	ManagementAndGeneral
Fundraising	121367	Fundraising

Travel Entrtnmnt Public Officials TravelEntrtnmntPublicOfficials

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices
Management And General	0	ManagementAndGeneral
Fundraising	0	Fundraising

Conferences Meetings ConferencesMeetings

Field	Value	IRS element (for citing)
Total	555092	Total
Program Services	477920	ProgramServices
Management And General	59943	ManagementAndGeneral
Fundraising	17229	Fundraising

Interest Interest

Field	Value	IRS element (for citing)
Total	13511373	Total
Program Services	12565577	ProgramServices
Management And General	945796	ManagementAndGeneral
Fundraising	0	Fundraising

Payments To Affiliates PaymentsToAffiliates

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices
Management And General	0	ManagementAndGeneral
Fundraising	0	Fundraising

Depreciation Depletion DepreciationDepletion

Field	Value	IRS element (for citing)
Total	25147092	Total
Program Services	22158566	ProgramServices
Management And General	2988526	ManagementAndGeneral
Fundraising	0	Fundraising

Insurance Insurance

Field	Value	IRS element (for citing)
Total	1573949	Total
Program Services	0	ProgramServices
Management And General	1573949	ManagementAndGeneral
Fundraising	0	Fundraising

Other Expenses OtherExpenses (3 entries)

DescriptionDescription	TotalTotal	Program ServicesProgramServices	Management And GeneralManagementAndGeneral	FundraisingFundraising
Research supplies	25494490	25494490	0	0
Equipment rental & maintenance	13419604	2338943	11035955	44706
Allocation of indirect costs	0	63383467	-63383467	0

All Other Expenses AllOtherExpenses

Field	Value	IRS element (for citing)
Total	11501064	Total
Program Services	8394150	ProgramServices
Management And General	2690587	ManagementAndGeneral
Fundraising	416327	Fundraising

Total Functional Expenses TotalFunctionalExpenses

Field	Value	IRS element (for citing)
Total	426207361	Total
Program Services	402721001	ProgramServices
Management And General	17886956	ManagementAndGeneral
Fundraising	5599404	Fundraising

Cash Non Interest Bearing CashNonInterestBearing

Field	Value	IRS element (for citing)
BOY	15274	BOY
EOY	9037	EOY

Savings And Temp Cash Investments SavingsAndTempCashInvestments

Field	Value	IRS element (for citing)
BOY	35926246	BOY
EOY	61510742	EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

Field	Value	IRS element (for citing)
BOY	32217752	BOY
EOY	34026493	EOY

Accounts Receivable AccountsReceivable

Field	Value	IRS element (for citing)
BOY	18479708	BOY
EOY	18046009	EOY

Other Notes Loans Receivable Net OtherNotesLoansReceivableNet

Field	Value	IRS element (for citing)
BOY	695757	BOY
EOY	621757	EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

Field	Value	IRS element (for citing)
BOY	1164713	BOY
EOY	1446837	EOY

Field	Value	IRS element (for citing)
Land Buildings Equipment Basis	626737871	LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec	301381978	LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

Field	Value	IRS element (for citing)
BOY	265178985	BOY
EOY	325355893	EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

Field	Value	IRS element (for citing)
BOY	58983024	BOY
EOY	125674643	EOY

Investments Other Securities InvestmentsOtherSecurities

Field	Value	IRS element (for citing)
BOY	48090908	BOY
EOY	40827536	EOY

Investments Program Related InvestmentsProgramRelated

Field	Value	IRS element (for citing)
BOY	59784031	BOY
EOY	71213967	EOY

Intangible Assets IntangibleAssets

Field	Value	IRS element (for citing)
BOY	0	BOY

Other Assets Total OtherAssetsTotal

Field	Value	IRS element (for citing)
BOY	35261915	BOY
EOY	35415567	EOY

Total Assets TotalAssets

Field	Value	IRS element (for citing)
BOY	555798313	BOY
EOY	714148481	EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

Field	Value	IRS element (for citing)
BOY	38025954	BOY
EOY	35760069	EOY

Grants Payable GrantsPayable

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Deferred Revenue DeferredRevenue

Field	Value	IRS element (for citing)
BOY	29178432	BOY
EOY	26711012	EOY

Tax Exempt Bond Liabilities TaxExemptBondLiabilities

Field	Value	IRS element (for citing)
BOY	266607522	BOY
EOY	372159052	EOY

Escrow Account Liability EscrowAccountLiability

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Loans From Officers Directors LoansFromOfficersDirectors

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Mort Notes Pybl Secured Invest Prop MortNotesPyblSecuredInvestProp

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Unsecured Notes Loans Payable UnsecuredNotesLoansPayable

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Other Liabilities OtherLiabilities

Field	Value	IRS element (for citing)
BOY	28981141	BOY
EOY	26486011	EOY

Total Liabilities TotalLiabilities

Field	Value	IRS element (for citing)
BOY	362793049	BOY
EOY	461116144	EOY

Field	Value	IRS element (for citing)
Follow SFAS117	X	FollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	114011264	BOY
EOY	162996337	EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	32312000	BOY
EOY	38223000	EOY

Permanently Restricted Net Assets PermanentlyRestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	46682000	BOY
EOY	51813000	EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	193005264	BOY
EOY	253032337	EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	555798313	BOY
EOY	714148481	EOY

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	X	InfoInScheduleOPartXI
Reconcilation Revenue Expenses	44398963	ReconcilationRevenueExpenses
Reconcilation Other Changes	15628110	ReconcilationOtherChanges
Method Of Accounting Accrual	X	MethodOfAccountingAccrual
Accountant Compile Or Review	0	AccountantCompileOrReview
FS Audited	1	FSAudited
Audit Committee	1	AuditCommittee
Financial Statement Separate	X	FinancialStatementSeparate
Federal Grant Audit Required	1	FederalGrantAuditRequired
Federal Grant Audit Performed	1	FederalGrantAuditPerformed

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Publicly Supported Org170b1 Avi	X	PubliclySupportedOrg170b1Avi

Gifts Grants Contrib Received170 GiftsGrantsContribReceived170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	301287235	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	322118651	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	309139679	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	345010973	CurrentTaxYearMinus1Year
Current Tax Year	387997752	CurrentTaxYear
Total	1665554290	Total

Tax Rev Levied For Org Benefit170 TaxRevLeviedForOrgBenefit170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	0	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	0	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	0	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	0	CurrentTaxYearMinus1Year
Current Tax Year	0	CurrentTaxYear
Total	0	Total

Value Srvc Fclts Furnished By Govt ValueSrvcFcltsFurnishedByGovt

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	0	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	0	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	0	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	0	CurrentTaxYearMinus1Year
Current Tax Year	0	CurrentTaxYear
Total	0	Total

Total170 Total170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	301287235	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	322118651	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	309139679	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	345010973	CurrentTaxYearMinus1Year
Current Tax Year	387997752	CurrentTaxYear
Total	1665554290	Total

Field	Value	IRS element (for citing)
Amounts Subst Contributors Total	0	AmountsSubstContributorsTotal
Public Support Total170	1665554290	PublicSupportTotal170

Gross Investment Income170 GrossInvestmentIncome170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	19279966	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	20511518	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	6696878	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	17583481	CurrentTaxYearMinus1Year
Current Tax Year	30871010	CurrentTaxYear
Total	94942853	Total

Net UBI NetUBI

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	0	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	18779	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	-38843	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	-62064	CurrentTaxYearMinus1Year
Current Tax Year	-85743	CurrentTaxYear
Total	-167871	Total

Other Income170 OtherIncome170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	0	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	0	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	0	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	0	CurrentTaxYearMinus1Year
Current Tax Year	0	CurrentTaxYear
Total	0	Total

Field	Value	IRS element (for citing)
Total Support	1760329272	TotalSupport
Gross Receipts From Admissions Etc	0	GrossReceiptsFromAdmissionsEtc
Public Support Pertcentage170	0.94616	PublicSupportPertcentage170
Public Support Pertcent Prior Year	0.95228	PublicSupportPertcentPriorYear
Thirty Three Percnt Tests CY170	X	ThirtyThreePercntTestsCY170

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

Field	Value	IRS element (for citing)
Contributor Number	RESTRICTED	ContributorNumber

Contributor Name Business ContributorNameBusiness

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor Address US ContributorAddressUS

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Aggregate Contributions	RESTRICTED	AggregateContributions

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbying

Field	Value	IRS element (for citing)
Filing Organizations Totals	0	FilingOrganizationsTotals

Total Direct Lobbying TotalDirectLobbying

Field	Value	IRS element (for citing)
Filing Organizations Totals	118859	FilingOrganizationsTotals

Total Lobbying Expenditures TotalLobbyingExpenditures

Field	Value	IRS element (for citing)
Filing Organizations Totals	118859	FilingOrganizationsTotals

Other Exempt Purpose Expenditures OtherExemptPurposeExpenditures

Field	Value	IRS element (for citing)
Filing Organizations Totals	425055557	FilingOrganizationsTotals

Total Exempt Purpose Expenditures TotalExemptPurposeExpenditures

Field	Value	IRS element (for citing)
Filing Organizations Totals	425174416	FilingOrganizationsTotals

Lobbying Nontaxable LobbyingNontaxableAmount

Field	Value	IRS element (for citing)
Filing Organizations Totals	1000000	FilingOrganizationsTotals

Grassroots Nontaxable GrassrootsNontaxableAmount

Field	Value	IRS element (for citing)
Filing Organizations Totals	250000	FilingOrganizationsTotals

Tot Lobbying Grassroot Minus Non Tx TotLobbyingGrassrootMinusNonTx

Field	Value	IRS element (for citing)
Filing Organizations Totals	0	FilingOrganizationsTotals

Tot Lobby Expend Mns Lobbying Nontx TotLobbyExpendMnsLobbyingNontx

Field	Value	IRS element (for citing)
Filing Organizations Totals	0	FilingOrganizationsTotals

Lobbying Nontaxable Amount2 LobbyingNontaxableAmount2

Field	Value	IRS element (for citing)
Current Year Minus3	1000000	CurrentYearMinus3
Current Year Minus2	1000000	CurrentYearMinus2
Current Year Minus1	1000000	CurrentYearMinus1
Current Year	1000000	CurrentYear
Total	4000000	Total

Field	Value	IRS element (for citing)
Lobbying Ceiling	$6,000,000	LobbyingCeilingAmount

Total Lobbying Expenditures2 TotalLobbyingExpenditures2

Field	Value	IRS element (for citing)
Current Year Minus3	118116	CurrentYearMinus3
Current Year Minus2	106714	CurrentYearMinus2
Current Year Minus1	112213	CurrentYearMinus1
Current Year	118859	CurrentYear
Total	455902	Total

Grassroots Nontaxable Amount2 GrassrootsNontaxableAmount2

Field	Value	IRS element (for citing)
Current Year Minus3	250000	CurrentYearMinus3
Current Year Minus2	250000	CurrentYearMinus2
Current Year Minus1	250000	CurrentYearMinus1
Current Year	250000	CurrentYear
Total	1000000	Total

Field	Value	IRS element (for citing)
Grassroots Ceiling	$1,500,000	GrassrootsCeilingAmount

Grassroots Lobbying Expenditures GrassrootsLobbyingExpenditures

Field	Value	IRS element (for citing)
Current Year Minus3	0	CurrentYearMinus3
Current Year Minus2	0	CurrentYearMinus2
Current Year Minus1	0	CurrentYearMinus1
Current Year	0	CurrentYear
Total	0	Total

Schedule D IRS990ScheduleD

Art Public Exhibition Amts ArtPublicExhibitionAmts

Field	Value	IRS element (for citing)
Revenues Included	0	RevenuesIncluded
Assets In Part X	710646	AssetsInPartX

Held Works Of Art Amts HeldWorksOfArtAmts

Field	Value	IRS element (for citing)
Revenues Included	0	RevenuesIncluded
Assets In Part X	0	AssetsInPartX

Field	Value	IRS element (for citing)
Collect Used For Public Exhibition	X	CollectUsedForPublicExhibition

Collection Used For Other CollectionUsedForOther

Field	Value	IRS element (for citing)
Collection Used For Other Purposes	X	CollectionUsedForOtherPurposes
Description Of Other Purposes	Per Donor Restriction, must maintain until 2030	DescriptionOfOtherPurposes

Field	Value	IRS element (for citing)
Solicited Assets For Sale	0	SolicitedAssetsForSale

Current Year CurrentYear

Field	Value	IRS element (for citing)
Beginning Of Year Balance	82001707	BeginningOfYearBalance
Contributions	14234000	Contributions
Investment Earnings Or Losses	14988000	InvestmentEarningsOrLosses
Grants Or Scholarships	0	GrantsOrScholarships
Other Expenditures	16994000	OtherExpenditures
Administrative Expenses	0	AdministrativeExpenses
End Of Year Balance	94229707	EndOfYearBalance

Current Year Minus1 Year CurrentYearMinus1Year

Field	Value	IRS element (for citing)
Beginning Of Year Balance	75830000	BeginningOfYearBalance
Contributions	5559524	Contributions
Investment Earnings Or Losses	7831043	InvestmentEarningsOrLosses
Grants Or Scholarships	0	GrantsOrScholarships
Other Expenditures	7218860	OtherExpenditures
Administrative Expenses	0	AdministrativeExpenses
End Of Year Balance	82001707	EndOfYearBalance

Current Year Minus2 Years CurrentYearMinus2Years

Field	Value	IRS element (for citing)
Beginning Of Year Balance	100751000	BeginningOfYearBalance
Contributions	4053000	Contributions
Investment Earnings Or Losses	-18913000	InvestmentEarningsOrLosses
Grants Or Scholarships	0	GrantsOrScholarships
Other Expenditures	10061000	OtherExpenditures
Administrative Expenses	0	AdministrativeExpenses
End Of Year Balance	75830000	EndOfYearBalance

Field	Value	IRS element (for citing)
Board Designated EOY Balance	0.68	BoardDesignatedEOYBalance
Permanent Endowment EOY Balance	0.26	PermanentEndowmentEOYBalance
Term Endowment EOY Balance	0.06	TermEndowmentEOYBalance
Endowments Held By Unrelated Orgs	0	EndowmentsHeldByUnrelatedOrgs
Endowments Held By Related Orgs	0	EndowmentsHeldByRelatedOrgs

Land Land

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	0	InvestmentCostOrOtherBasis
Other Cost Or Other Basis	52389138	OtherCostOrOtherBasis
Book Value	52389138	BookValue

Buildings Buildings

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	0	InvestmentCostOrOtherBasis
Other Cost Or Other Basis	376821746	OtherCostOrOtherBasis
Depreciation	217559101	Depreciation
Book Value	159262645	BookValue

Leasehold Improvements LeaseholdImprovements

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	0	InvestmentCostOrOtherBasis
Other Cost Or Other Basis	0	OtherCostOrOtherBasis
Depreciation	0	Depreciation
Book Value	0	BookValue

Equipment Equipment

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	0	InvestmentCostOrOtherBasis
Other Cost Or Other Basis	164346906	OtherCostOrOtherBasis
Depreciation	83822877	Depreciation
Book Value	80524029	BookValue

Other Land Buildings OtherLandBuildings

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	0	InvestmentCostOrOtherBasis
Other Cost Or Other Basis	33180081	OtherCostOrOtherBasis
Depreciation	0	Depreciation
Book Value	33180081	BookValue

Field	Value	IRS element (for citing)
Total Of Book Value Land Buildings	325355893	TotalOfBookValueLandBuildings

Other Securities OtherSecurities (7 entries)

DescriptionDescription	Book ValueBookValue	Method Of ValuationMethodOfValuation
Mortgage-Backed Securities	1868768	F
Collaterized Mortgage Oblig	371278	F
Asset Backed Securities	195060	F
Hedge Funds	4736728	F
Limited Partnerships	22991634	F
Ikaria Stock	9837185	F
Other	826883	F

Field	Value	IRS element (for citing)
Total Of Book Value Securities	40827536	TotalOfBookValueSecurities

Investments Program Related InvestmentsProgramRelated

Field	Value	IRS element (for citing)
Description	Investment in Seattle Cancer Care Alliance	Description
Book Value	71213967	BookValue
Method Of Valuation	C	MethodOfValuation

Field	Value	IRS element (for citing)
Total Of Book Value Program Related	71213967	TotalOfBookValueProgramRelated

Other Assets OtherAssets (4 entries)

DescriptionDescription	Book ValueBookValue
Beneficial Interest in Perpetual Trusts	27330741
Rental Property	5555444
Deferred Financing Costs	2530782
Others	-1400

Field	Value	IRS element (for citing)
Total Book Value Other Assets	35415567	TotalBookValueOtherAssets

Other Liabilities OtherLiabilities

Field	Value	IRS element (for citing)
Description	Deferred Credit Cash Flow Hedge	Description
Amount	$26,486,011	Amount

Field	Value	IRS element (for citing)
Total Of Amounts	26486011	TotalOfAmounts
Total Revenue	470606324	TotalRevenue
Total Expenses	426207361	TotalExpenses
Excess Or Deficit For Year	44398963	ExcessOrDeficitForYear
Net Unrealized GL On Investments	13133181	NetUnrealizedGLOnInvestments
Donated Services And Facilities	0	DonatedServicesAndFacilities
Investment Expenses	0	InvestmentExpenses
Prior Period Adjustments	0	PriorPeriodAdjustments
Other	$2,494,930	OtherAmount
Total Adjustments	15628111	TotalAdjustments
Excess Or Deficit Per FS	60027074	ExcessOrDeficitPerFS
Tot Revenue Etc Audited Fincl Stmt	469573378	TotRevenueEtcAuditedFinclStmt
Net Unrealized Gains Investments	0	NetUnrealizedGainsInvestments
Donated Srvc And Use Of Facilities	0	DonatedSrvcAndUseOfFacilities
Recoveries Of Prior Year Grants	0	RecoveriesOfPriorYearGrants
Other Revenues	0	OtherRevenues
Revenue Not Rptd F990	0	RevenueNotRptdF990
Revenue Subtotal	469573378	RevenueSubtotal
Investment Expenses Not Included	1032946	InvestmentExpensesNotIncluded
Other Revenues Not Included	0	OtherRevenuesNotIncluded
Revenue Not Rptd On Fin Stmt	1032946	RevenueNotRptdOnFinStmt
Total Revenue Per Form990	470606324	TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt	425174416	TotExpensesEtcAuditedFinclStmt
Donated Services Use Of Facilities	0	DonatedServicesUseOfFacilities
Prior Year Adjustments	0	PriorYearAdjustments
Losses Reported	0	LossesReported
Other Expenses Included	0	OtherExpensesIncluded
Expenses Not Rptd F990	0	ExpensesNotRptdF990
Expenses Subtotal	425174416	ExpensesSubtotal
Investment Expenses Not Included2	1032945	InvestmentExpensesNotIncluded2
Other Expenses Not Included	0	OtherExpensesNotIncluded
Expenses Not Rptd On Fin Stmt	1032945	ExpensesNotRptdOnFinStmt
Total Expenses Per Form990	426207361	TotalExpensesPerForm990

Form990 Schedule D Part XIV Form990ScheduleDPartXIV (3 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
SchD_P03_S00_L04	Schedule D, Part III, Line 4	In January 2010, the QTIP Trust of the 1993 Kullman Family Trust donated to the Center a collection of forty black and white photographs which had an appraised value of $710,646 at the time of the donation. The Artwork Donation Agreement requires the Center to display the Artwork as a collection at its main campus in Seattle, Washington for at least twenty years. The Artwork Donation Agreement states that "the Center shall have the right to use and display the Artwork in the manner that best serves the interest of the Center." At the end of the required twenty year display period, the Center will determine if opportunities exist that may allow the value of the donated artwork to fund the Center's research.
SchD_P05_S00_L04	Schedule D, Part V, Line 4	Spending Policy - The Center's spending policy for endowment funds is to appropriate for distribution each year 5% percent of the endowment fund's average fair value over the prior three years, provided that the fair value of the endowment fund exceeds the corpus. For a portion of the Center's Board-designated investments, the Center does not appropriate for distribution any amount of investment return as all of the return earned is held to grow the fund for future repayment of long-term debt. For the remaining board designated investments, the Center makes all investment return available for expenditure on programmatic initiatives. In establishing these policies, the Center considered the long-term expected returns on its endowment and Board-designated investments.
SchD_P11_S00_L08	Schedule D, Part XI, Line 8	Change in net unrealized fair value of swap instruments.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	1	GrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable (7 entries)

RegionRegion	Number Of EmployeesNumberOfEmployees	Type Of Activities ConductedTypeOfActivitiesConducted	Specific Services ProvidedSpecificServicesProvided	Total ExpendituresTotalExpenditures
Central America and the Caribbean	0	Grantmaking	N/A	719111
East Asia and the Pacific	0	Grantmaking	N/A	142614
Europe (including Iceland and Greenland)	0	Grantmaking	N/A	1550858
North America (including Canada and Mexico, but not the United States)	0	Grantmaking	N/A	850758
South America	0	Grantmaking	N/A	521874
Sub-Saharan Africa	0	Grantmaking	N/A	1989083
Sub-Saharan Africa	1	Program Services	Research	71427

Field	Value	IRS element (for citing)
Total Number Of Offices	0	TotalNumberOfOffices
Total Number Of Employees	1	TotalNumberOfEmployees
Total Amount Spent	5845725	TotalAmountSpent

Grants To Orgs Outside US GrantsToOrgsOutsideUS (38 entries)

RegionRegion	Purpose Of GrantPurposeOfGrant	Amount Of Cash GrantAmountOfCashGrant	Manner Of Cash DisbursementMannerOfCashDisbursement	Description Of Non Cash AssistanceDescriptionOfNonCashAssistance	Method Of ValuationMethodOfValuation
Central America and the Caribbean	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	566941	Wire transfer	N/A	N/A
Central America and the Caribbean	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	152170	Wire transfer	N/A	N/A
East Asia and the Pacific	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI	142614	Wire transfer	N/A	N/A
Europe (including Iceland and Greenland)	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI	23052	Wire transfer	N/A	N/A
Europe (including Iceland and Greenland)	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI	9609	Wire transfer	N/A	N/A
Europe (including Iceland and Greenland)	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR	186153	Wire transfer	N/A	N/A
Europe (including Iceland and Greenland)	HVTN LABORATORY PROGRAM	169981	Wire transfer	N/A	N/A
Europe (including Iceland and Greenland)	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS: HIV PR	150036	Wire transfer	N/A	N/A
Europe (including Iceland and Greenland)	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	682561	Wire transfer	N/A	N/A
Europe (including Iceland and Greenland)	MODELING PROSTATE CANCER CONTROL: PREVENTION, SCREENING,	197807	Wire transfer	N/A	N/A
Europe (including Iceland and Greenland)	THE PATHOGENESIS OF FMD: FACIOSCAPULOHUMERAL MUSCULAR	105504	Wire transfer	N/A	N/A
Europe (including Iceland and Greenland)	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI	26156	Wire transfer	N/A	N/A
North America (including Canada and Mexico, but not the United States)	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI	57918	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	EVALUATION OF A HEPATITIS B OUTREACH INTERVENTION FOR CA	38246	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	EXPANSION OF CARDIAC AND HEMATOPOIETIC PREGENITORS BY WN	167485	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	HVTN LABORATORY PROGRAM	14173	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	THE GENETICS OF PARALLEL REPRODUCTIVE ISOLATION IN STICK	30722	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	THE PACIFIC NORTHWEST PROSTATE CANCER SPORE	307340	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	THE STATISTICAL AND COMPUTATIONAL ANALYSIS OF FLOW CYTOM	82994	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	TREC: MECHANISMS OF ENERGY BALANCE AND CANCER PREVENTION	7402	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	WASHINGTON VACCINE ALLIANCE	144477	Check	N/A	N/A
South America	BREAST HEALTH GLOBAL INITIATIVE	21400	Wire transfer	N/A	N/A
South America	IMPROVING BREAST CANCER SCREENING AT THE PRIMARY CARE LE	17246	Wire transfer	N/A	N/A
South America	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	279649	Wire transfer	N/A	N/A
South America	READINESS ASSESSMENT FOR IMPLEMENTATION OF BREAST CANCER	5376	Wire transfer	N/A	N/A
South America	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	198203	Wire transfer	N/A	N/A
Sub-Saharan Africa	EARLY AND REINFECTION IN HIGH RISK WOMEN	43111	Wire transfer	N/A	N/A
Sub-Saharan Africa	HVTN LABORATORY PROGRAM	248294	Wire transfer	N/A	N/A
Sub-Saharan Africa	HVTN LABORATORY PROGRAM	594430	Wire transfer	N/A	N/A
Sub-Saharan Africa	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	45946	Check	N/A	N/A
Sub-Saharan Africa	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	193577	Wire transfer	N/A	N/A
Sub-Saharan Africa	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	351175	Wire transfer	N/A	N/A
Sub-Saharan Africa	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	13500	Wire transfer	N/A	N/A
Sub-Saharan Africa	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	5037	Wire transfer	N/A	N/A
Sub-Saharan Africa	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	418842	Wire transfer	N/A	N/A
Sub-Saharan Africa	ADULT LEUKEMIA RESEARCH CENTER	22150	Wire transfer	N/A	N/A
Sub-Saharan Africa	IMPACT OF HIV AND HHV-8 CO-INFECTION ON ANTIRETROVIRAL T	33921	Wire transfer	N/A	N/A
Sub-Saharan Africa	ASSOCIATION BETWEEEN HIV AND SURVIVAL AFTER CANCER DIAGN	15006	Wire transfer	N/A	N/A

Field	Value	IRS element (for citing)
Total Number Of501c3 Orgs	1	TotalNumberOf501c3Orgs
Total Number Of Other Orgs	29	TotalNumberOfOtherOrgs

Grants To Ind Outside US GrantsToIndOutsideUS (19 entries)

Type Of AssistanceTypeOfAssistance	RegionRegion	Number Of RecipientsNumberOfRecipients	Amount Of Cash GrantAmountOfCashGrant	Manner Of Cash DisbursementMannerOfCashDisbursement	Description Of Non Cash AssistanceDescriptionOfNonCashAssistance	Method Of ValuationMethodOfValuation
Airfare	Central America and the Caribbean	1	1093	Check	N/A	N/A
Airfare	East Asia and the Pacific	1	101423	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	East Asia and the Pacific	1	26030	Check	N/A	N/A
Airfare	Europe (including Iceland and Greenland)	1	121277	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	Europe (including Iceland and Greenland)	1	39425	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	Europe (including Iceland and Greenland)	1	2222	Wire	N/A	N/A
Airfare	Middle East and North Africa	1	2110	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	Middle East and North Africa	1	526	Check	N/A	N/A
Airfare	North America (including Canada and Mexico, but not the United States)	1	16923	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	North America (including Canada and Mexico, but not the United States)	1	4693	Check	N/A	N/A
Airfare	Russia and the newly independent States	1	13777	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	Russia and the newly independent States	1	10684	Check	N/A	N/A
Airfare	South America	1	22519	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	South America	1	2531	Check	N/A	N/A
Airfare	South Asia	1	4330	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	South Asia	1	360	Check	N/A	N/A
Airfare	Sub-Saharan Africa	1	166160	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	Sub-Saharan Africa	1	22086	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	Sub-Saharan Africa	1	914	Wire	N/A	N/A

Field	Value	IRS element (for citing)
Transfer To Foreign Corp	0	TransferToForeignCorp
Interest In Foreign Trust	0	InterestInForeignTrust
Own Foreign Corp	0	OwnForeignCorp
Passive Foreign Invest Co	0	PassiveForeignInvestCo
Foreign Partnership	0	ForeignPartnership
Boycott Countries	0	BoycottCountries

Form990 Schedule F Part V Form990ScheduleFPartV (2 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
SchF_P01_S00_L02	Schedule F, Part I, Line 2	Procedure for Monitoring the Use of Grant Funds Once the notice of award has been received and the Center project ID activated, the subaward can be set up. The structure of the subaward will depend on how the Prime is set up. Generally at the Center, a new PO is requisitioned for each subaward for each year of a project. This allows the RC to closely monitor subaward invoices and encumbrances. For our Subrecipients, it means a separate budget ID and final invoice each year. Carryover between years is not automatic. There are 5 primary steps. 1) Step one is within OSR. The Grant Specialist notifies the Contract Specialist that a grant which includes a subaward has been funded, and provides to the Contract Specialist a copy of the award, the signed subaward application (if available) and any special instructions. A signed subaward application is important because it shows that the Subrecipient organization has reviewed and approved the budget and scope of work. 2) The Research Coordinator (RC) sends the Contract Specialist a Subcontract Acquisition Form (SAF). This form provides authorization for the Contract Specialist to issue the subaward, and included a scope of work, budget and pertinent subrecipient information. It is necessary to provide the scope of work and budget on the SAF as these items may have changed from what was originally submitted in the subaward application. 3) The Contract Specialist requisitions the subaward PO, which the RC must approve. An e-mail is sent to the RC notifying them that the requisition is pending and requires approval. Because OSR does not have funds commitment authority the RC is required to approve all requisition. 4) OSR collects information required to correctly set up the subaward. These items include IRO and IACUC approval dates, confirmation of subaward F&A rates and A-133 Audit reports, review of Prime special terms and conditions to determine flow-down, confirmation that the Subrecipients is not debarred, and other similar regulatory and administrative requirements. While much of this information is collected by OSR, the RC may, in addition to completing the SAF, be asked to assist in the collection of some of the documentation. 5) OSR writes the subaward agreement, and mails it to the Subrecipients for signature. Some agreements can be signed by OSR before mailing, while others will be sent unsigned. This is determined by the Contract Specialist based on the terms of award and status of administrative and regulatory requirements. A copy of the initial subaward is sent to the RC. Once the subaward has been fully signed, a copy is sent to the RC for their files. No invoices should be approved by the RC until they have received a fully executed agreement.
SchF_P04_S00_L00	Schedule F, Part IV	Schedule F, Part III, Number of Recipients - The data presented above are employee incurred foreign travel costs which we believe meet the IRS Schedule F, Part III's request for grants and other assistance to "U.S. individuals for foreign activity." As such, column (c)'s request for "the number of recipients that received the type of assistance in that region" does not appear to apply foreign travel cost incurred by U.S. individuals.

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	X	MailSolicitations
Email Solicitations	X	EmailSolicitations
In Person Solicitations	X	InPersonSolicitations
Solicitation Of Non Govt Grants	X	SolicitationOfNonGovtGrants
Solicitation Of Govt Grants	X	SolicitationOfGovtGrants
Special Fundraising Events	X	SpecialFundraisingEvents
Agreement Ref Fundraising	1	AgreementRefFundraising

Fundraiser Activity Information FundraiserActivityInformation

Name Of Organization NameOfOrganization

Field	Value	IRS element (for citing)
Business Name Line1	Lewis Kennedy Associates Inc	BusinessNameLine1

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	PO Box 3257	AddressLine1
City	Portland	City
State	OR	State
ZIP Code	97208	ZIPCode

Field	Value	IRS element (for citing)
Activity	Direct Mail	Activity
Fundraiser Control Of Funds	0	FundraiserControlOfFunds
Gross Receipts	600983	GrossReceipts
Amount Retained By Contractor	59204	AmountRetainedByContractor
Net To Organization	541779	NetToOrganization

Field	Value	IRS element (for citing)
Total Gross Receipts	600983	TotalGrossReceipts
Total Retained By Contractors	59204	TotalRetainedByContractors
Total Net To Organization	541779	TotalNetToOrganization
Licensed States	AK	LicensedStates
Licensed States	AL	LicensedStates
Licensed States	AR	LicensedStates
Licensed States	AZ	LicensedStates
Licensed States	CA	LicensedStates
Licensed States	CO	LicensedStates
Licensed States	CT	LicensedStates
Licensed States	FL	LicensedStates
Licensed States	GA	LicensedStates
Licensed States	HI	LicensedStates
Licensed States	IL	LicensedStates
Licensed States	KS	LicensedStates
Licensed States	KY	LicensedStates
Licensed States	MA	LicensedStates
Licensed States	MD	LicensedStates
Licensed States	ME	LicensedStates
Licensed States	MI	LicensedStates
Licensed States	MN	LicensedStates
Licensed States	MO	LicensedStates
Licensed States	MS	LicensedStates
Licensed States	NC	LicensedStates
Licensed States	ND	LicensedStates
Licensed States	NH	LicensedStates
Licensed States	NJ	LicensedStates
Licensed States	NM	LicensedStates
Licensed States	NY	LicensedStates
Licensed States	OH	LicensedStates
Licensed States	OK	LicensedStates
Licensed States	OR	LicensedStates
Licensed States	PA	LicensedStates
Licensed States	RI	LicensedStates
Licensed States	SC	LicensedStates
Licensed States	TN	LicensedStates
Licensed States	UT	LicensedStates
Licensed States	VA	LicensedStates
Licensed States	WA	LicensedStates
Licensed States	WI	LicensedStates
Licensed States	WV	LicensedStates

Events Information EventsInformation

Field	Value	IRS element (for citing)
Name Of Event1	Hutch Holiday Gala	NameOfEvent1
Gross Receipts Event1	6131259	GrossReceiptsEvent1
Charitable Contributions Event1	5798259	CharitableContributionsEvent1
Gross Revenue Event1	333000	GrossRevenueEvent1
Cash Prizes Event1	0	CashPrizesEvent1
Non Cash Prizes Event1	0	NonCashPrizesEvent1
Rent Facility Costs Event1	0	RentFacilityCostsEvent1
Food And Beverage Event1	193881	FoodAndBeverageEvent1
Entertainment Event1	33123	EntertainmentEvent1
Other Direct Expenses Event1	195027	OtherDirectExpensesEvent1
Name Of Event2	Climb to Fight Breast Cancer	NameOfEvent2
Gross Receipts Event2	459796	GrossReceiptsEvent2
Charitable Contributions Event2	459796	CharitableContributionsEvent2
Gross Revenue Event2	0	GrossRevenueEvent2
Cash Prizes Event2	0	CashPrizesEvent2
Non Cash Prizes Event2	0	NonCashPrizesEvent2
Rent Facility Costs Event2	0	RentFacilityCostsEvent2
Food And Beverage Event2	0	FoodAndBeverageEvent2
Entertainment Event2	0	EntertainmentEvent2
Other Direct Expenses Event2	309833	OtherDirectExpensesEvent2
Total Number Of Other Events	7	TotalNumberOfOtherEvents
Gross Receipts Other Events	1345896	GrossReceiptsOtherEvents
Charitable Contrib Other Events	1158231	CharitableContribOtherEvents
Gross Revenue Other Events	187665	GrossRevenueOtherEvents
Cash Prizes Other Events	0	CashPrizesOtherEvents
Non Cash Prizes Other Events	0	NonCashPrizesOtherEvents
Rent Facility Costs Other Events	0	RentFacilityCostsOtherEvents
Food And Beverage Other Events	87728	FoodAndBeverageOtherEvents
Entertainment Other Events	26186	EntertainmentOtherEvents
Other Direct Expenses Other Events	134135	OtherDirectExpensesOtherEvents
Gross Receipts Total	7936951	GrossReceiptsTotal
Charitable Contributions Total	7416286	CharitableContributionsTotal
Gross Revenue Total Events	520665	GrossRevenueTotalEvents
Cash Prizes Total Events	0	CashPrizesTotalEvents
Non Cash Prizes Total Events	0	NonCashPrizesTotalEvents
Rent Facility Costs Total Events	0	RentFacilityCostsTotalEvents
Food And Beverage Total Events	281609	FoodAndBeverageTotalEvents
Entertainment Total Events	59309	EntertainmentTotalEvents
Other Direct Expenses Total Events	638995	OtherDirectExpensesTotalEvents
Direct Expense Summary Events	979913	DirectExpenseSummaryEvents
Net Income Summary	-459248	NetIncomeSummary

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Records Maintained	1	RecordsMaintained

Recipient Table RecipientTable (327 entries)

Address Line1AddressUS/AddressLine1	Address Line2AddressUS/AddressLine2	CityAddressUS/City	StateAddressUS/State	ZIP CodeAddressUS/ZIPCode	EIN Of RecipientEINOfRecipient	IRC SectionIRCSection	Amount Of Cash GrantAmountOfCashGrant	Amount Of Non Cash AssistanceAmountOfNonCashAssistance	Method Of ValuationMethodOfValuation	Description Of Non Cash AssistanceDescriptionOfNonCashAssistance	Purpose Of GrantPurposeOfGrant	Business Name Line2RecipientNameBusiness/BusinessNameLine2
ADMINISTRATORS OF THE TULANE
800 EAST COMMERCE RD	SUITE 203	HARAHAN	LA	70123	720423889	501(c)(3)	62631	0	N/A	N/A	HVTN LABORATORY PROGRAM
AIDS RESEARCH ALLIANCE OF AMERICA
1400 S GRAND AVE	SUITE 701	LOS ANGELES	CA	90015	954264845	501(c)(3)	988421	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
BATTELLE MEMORIAL INSTITUTE
P O BOX 84262		SEATTLE	WA	981245562	314379427	501(c)(3)	49042	0	N/A	N/A	RADIATION DOSE-DEPENDENT INTERVENTIONS	ATTN CASHIER
BATTELLE MEMORIAL INSTITUTE
P O BOX 84262		SEATTLE	WA	981245562	314379427	501(c)(3)	719398	0	N/A	N/A	IMPROVING EARLY DETECTION OF BREAST CANCER WITH A BLOOD	ATTN CASHIER
BATTELLE MEMORIAL INSTITUTE
P O BOX 84262		SEATTLE	WA	981245562	314379427	501(c)(3)	8791	0	N/A	N/A	BREAST CANCER BIOMARKER DISCOVERY CONSORTIUM - SUPPLEMEN	ATTN CASHIER
BATTELLE MEMORIAL INSTITUTE
P O BOX 84262		SEATTLE	WA	981245562	314379427	501(c)(3)	62791	0	N/A	N/A	THE BREAST CANCER BIOMARKER DISCOVERY CONSORTIUM- PHASE	ATTN CASHIER
BAYLOR COLLEGE OF MEDICINE
BCM280	ONE BAYLOR PLAZA	HOUSTON	TX	77030	741613878	501(c)(3)	732992	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
BAYLOR COLLEGE OF MEDICINE
BCM 206	ONE BAYLOR PLAZA	HOUSTON	TX	77030	741613878	501(c)(3)	31613	0	N/A	N/A	CORE ASSAYS MRLI - W1 W3	OFFICE OF GRANTS & CONTRACTS
BAYSTATE MEDICAL CENTER INC
P O BOX 414168		BOSTON	MA	022414168	042790311	501(c)(3)	14700	0	N/A	N/A	A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L
BECKMAN RESEARCH INSTITUTE OF THE
1500 EAST DUARTE ROAD		DUARTE	CA	910103012	953432210	501(c)(3)	18054	0	N/A	N/A	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI
BECKMAN RESEARCH INSTITUTE OF THE
1500 EAST DUARTE ROAD		DUARTE	CA	910103012	953432210	501(c)(3)	14074	0	N/A	N/A	TARGETED THERAPY OF ALL WITH GENE-MODIFIED CENTRAL MEMOR
BENAROYA RESEARCH INSTITUTE
1201 NINTH AVE		SEATTLE	WA	98101	910653422	501(c)(3)	89657	0	N/A	N/A	MIXED HEMATOPOIETIC CHIMERISM AFTER STEM CELL ALLOGRAFTS
BENAROYA RESEARCH INSTITUTE
1201 NINTH AVE		SEATTLE	WA	98101	910653422	501(c)(3)	42099	0	N/A	N/A	HEMATOPOIETIC CELL TRANSPLANTATION AND IRON OVERLOAD
BETH ISRAEL DEACONESS MEDICAL CENTER
330 BROOKLINE AVENUE	ROOM 262	BOSTON	MA	02215	042103881	501(c)(3)	48998	0	N/A	N/A	HVTN LABORATORY PROGRAM	RESEARCH FINANCE OFFICE BR 109
BOARD OF TRUSTEES OF THE LELAND
P O BOX 44253		SAN FRANCISCO	CA	941444253	941156365	501(c)(3)	55407	0	N/A	N/A	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD
BOARD OF TRUSTEES OF THE LELAND
P O BOX 44253		SAN FRANCISCO	CA	941444253	941156365	501(c)(3)	10191	0	N/A	N/A	STATISTICAL METHODS FOR INTEGRATIVE ANALYSIS OF GENOMICS
BOARD OF TRUSTEES OF THE LELAND
P O BOX 44253		SAN FRANCISCO	CA	941444253	941156365	501(c)(3)	74861	0	N/A	N/A	IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC
BOARD OF TRUSTEES OF THE LELAND
P O BOX 44253		SAN FRANCISCO	CA	941444253	941156365	501(c)(3)	126914	0	N/A	N/A	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM
BOARD OF TRUSTEES OF THE LELAND
P O BOX 44253		SAN FRANCISCO	CA	941444253	941156365	501(c)(3)	149586	0	N/A	N/A	CANCER CENTER SUPPORT GRANT (COMPREHENSIVE)
BOARD OF TRUSTEES UNIVERSITY OF ILLINOIS
P O BOX 20787		SPRINGFIELD	IL	627080787	376000511	University	8615	0	N/A	N/A	HVTN LABORATORY PROGRAM	GRANTS & CONTRACTS
BOARD OF TRUSTEES UNIVERSITY OF ILLINOIS
P O BOX 20787		SPRINGFIELD	IL	627080787	376000511	University	1146649	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	GRANTS & CONTRACTS
BRIGHAM AND WOMENS HOSPITAL INC
P O BOX 3887	FINANCE	BOSTON	MA	022413887	042312909	501(c)(3)	947595	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	BANK OF AMERICA NA
BRIGHAM AND WOMENS HOSPITAL INC
P O BOX 3887	FINANCE	BOSTON	MA	022413887	042312909	501(c)(3)	118798	0	N/A	N/A	BIOCONDUCTOR- AN OPEN COMPUTING RESOURCE FOR GENOMICS	BANK OF AMERICA NA
BRIGHAM AND WOMENS HOSPITAL INC
P O BOX 3887	FINANCE	BOSTON	MA	022413887	042312909	501(c)(3)	76069	0	N/A	N/A	BARRETT'S ESOPHAGUS- PREDICTORS OF PROGRESSION	BANK OF AMERICA NA
BRIGHAM AND WOMENS HOSPITAL INC
P O BOX 3887	FINANCE	BOSTON	MA	022413887	042312909	501(c)(3)	176148	0	N/A	N/A	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR	BANK OF AMERICA NA
BRIGHAM AND WOMENS HOSPITAL INC
P O BOX 3887	FINANCE	BOSTON	MA	022413887	042312909	501(c)(3)	1061377	0	N/A	N/A	GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN C	BANK OF AMERICA NA
BROAD INSTITUTE INC
7 CAMBRIDGE CENTER	OFFICE 7112L	CAMBRIDGE	MA	02142	263428781	501(c)(3)	998654	0	N/A	N/A	IMPROVING EARLY DETECTION OF BREAST CANCER WITH A BLOOD	CASH MANAGER
BROAD INSTITUTE INC
7 CAMBRIDGE CENTER		CAMBRIDGE	MA	02142	263428781	501(c)(3)	681793	0	N/A	N/A	MEASUREMENT OF CANCER-ASSOCIATED BIOMARKER PROTEINS IN C	ATTN AMY GALAVIZ
BROAD INSTITUTE INC
7 CAMBRIDGE CENTER	OFFICE 7112L	CAMBRIDGE	MA	02142	263428781	501(c)(3)	1095058	0	N/A	N/A	GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN C	CASH MANAGER
BROAD INSTITUTE INC
7 CAMBRIDGE CENTER	OFFICE 7112L	CAMBRIDGE	MA	02142	263428781	501(c)(3)	36585	0	N/A	N/A	BREAST CANCER BIOMARKER DISCOVERY CONSORTIUM - SUPPLEMEN	CASH MANAGER
BROAD INSTITUTE INC
7 CAMBRIDGE CENTER	OFFICE 7112L	CAMBRIDGE	MA	02142	263428781	501(c)(3)	248585	0	N/A	N/A	THE BREAST CANCER BIOMARKER DISCOVERY CONSORTIUM- PHASE	CASH MANAGER
CALIFORNIA RURAL INDIAN HEALTH BOARD INC
4400 AUBURN BLVD	2ND FLOOR	SACRAMENTO	CA	95841	237052541	501(c)(3)	49485	0	N/A	N/A	A MULTI-STATE STUDY OF CANCER TREATMENT AND OUTCOME AMON
CANCER RESEARCH AND BIOSTATISTICS
1730 MINOR AVENUE	SUITE 1900	SEATTLE	WA	981011468	911828539	501(c)(3)	2681979	0	N/A	N/A	SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER
CANCER RESEARCH AND BIOSTATISTICS
1730 MINOR AVENUE	SUITE 1900	SEATTLE	WA	981011468	911828539	501(c)(3)	151771	0	N/A	N/A	CENTER FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CANCER
CASE WESTERN RESERVE UNIVERSITY
10900 EUCLID AVE		CLEVELAND	OH	441067037	341018992	501(c)(3)	207949	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	OFFICE OF SPONSORED PROJECTS ACCOUNTING
CASE WESTERN RESERVE UNIVERSITY
10900 EUCLID AVE		CLEVELAND	OH	441067037	341018992	501(c)(3)	114325	0	N/A	N/A	IDENTIFY AND VALIDATE NOVEL EPIGENETIC MOLECULAR MARKERS	OFFICE OF SPONSORED PROJECTS ACCOUNTING
CEDARS SINAI MEDICAL CENTER
8700 BEVERLY BLVD	SUITE 1150 65-WIL	LOS ANGELES	CA	900481865	951644600	501(c)(3)	97555	0	N/A	N/A	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM	SPONSORED RESEARCH & FUNDS ADMINISTRATION
CENTER FOR MEDICAL TECHNOLOGY POLICY
401 EAST PRATT STREET	SUITE 631	BALTIMORE	MD	21202	261409553	501(c)(3)	252366	0	N/A	N/A	CENTER FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CANCER	WORLD TRADE CENTER BALTIMORE
CHILDREN'S HOSPITAL MEDICAL CENTER DBA
3333 BURNET AVENUE		CINCINNATI	OH	452293039	310833936	501(c)(3)	114764	0	N/A	N/A	DEVELOPMENT OF SAFE AND EFFICIENT GENE THERAPY STRATEGIE	ACCOUNTING OFFICE MLC-5000
CITY AND COUNTY OF SAN FRANCISCO
1380 HOWARD ST RM 417		SAN FRANCISCO	CA	94103	946000417	CITY-CNTY OF SF	296975	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
CITY OF PHILADELPHIA
1401 JFK BLVD	ROOM 1380 MSB	PHILADELPHIA	PA	19102	236003047	CITY OF PHILADELPHIA	62443	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HIV PR
CLINICAL ALLIANCE FOR RESEARCH AND
3289 WOODBURN ROAD	SUITE 250	ANNANDALE	VA	22003	202651141		178847	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
COLORADO STATE UNIVERSITY
6015 CAMPUS DELIVERY - OSP		FORT COLLINS	CO	805236015	846000545	University	146595	0	N/A	N/A	TREC- MECHANISMS OF ENERGY BALANCE AND CANCER PREVENTION	CASHIER'S OFFICE
COMSYS INFO TECHNOLOGY SERVICES LLC
P O BOX 60260		CHARLOTTE	NC	28260	751300240		212450	0	N/A	N/A	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT
CORNELL UNIVERSITY
P O BOX 22		ITHACA	NY	148510022	150532082	501(c)(3)	129829	0	N/A	N/A	TOWARDS A MODEL OF FANCONI ANEMIA
DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVENUE	MAIL STOP BP451	BOSTON	MA	02215	042263040	501(c)(3)	39754	0	N/A	N/A	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD	RESEARCH ACCOUNTING
DANA FARBER CANCER INSTITUTE
LW 258		BOSTON	MA	02215	042263040	501(c)(3)	97500	0	N/A	N/A	BLOOD TESTS FOR THE EARLY DETECTION OF LUNG CANCER	MED ONCOLOGY GMO
DISTRICT OF COLUMBIA GOV-DC TREASURY
899 NORTH CAPITOL NE	4TH FLOOR	WASHINGTON	DC	20002	536001131	DISTRICT OF COLUMBIA	629591	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HIV PR
DUKE UNIVERSITY
2200 WEST MAIN STREET	SUITE 300	DURHAM	NC	277054677	560532129	501(c)(3)	2138648	0	N/A	N/A	HVTN LABORATORY PROGRAM	OFFICE OF SPONSORED PROGRAMS
DUKE UNIVERSITY
2200 WEST MAIN STREET	SUITE 300	DURHAM	NC	277054677	560532129	501(c)(3)	31274	0	N/A	N/A	MECHANISM-BASED CLASSIFICATION AND TARGETING OF CASTRATI	OFFICE OF SPONSORED PROGRAMS
EMORY UNIVERSITY
1599 CLIFTON ROAD NE	4TH FLOOR MS 1599-001-1BH	ATLANTA	GA	303224250	580566256	501(c)(3)	597689	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	GRANTS & CONTRACTS ACCOUNTING
EMORY UNIVERSITY
1599 CLIFTON ROAD NE	4TH FLOOR MS 1599-001-1BH	ATLANTA	GA	303224250	580566256	501(c)(3)	799367	0	N/A	N/A	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF	GRANTS & CONTRACTS ACCOUNTING
EMORY UNIVERSITY
1599 CLIFTON ROAD NE	4TH FLOOR MS 1599-001-1BH	ATLANTA	GA	303224250	580566256	501(c)(3)	132381	0	N/A	N/A	CONTAINING BIOTERRORISM AND EMERGING INFECTIOUS DISEASES	GRANTS & CONTRACTS ACCOUNTING
EXPONENT INC
P O BOX 200283	DEPT 002	DALLAS	TX	753200283	770218904		10500	0	N/A	N/A	THE FEASIBILITY OF EARLIER DETECTION OF OVARIAN CANCER U
FENWAY COMMUNITY HEALTH
1340 BOYLSTON ST	9TH FLOOR	BOSTON	MA	02215	042510564	501(c)(3)	866490	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	FINANCE
FENWAY COMMUNITY HEALTH
1340 BOYLSTON ST	9TH FLOOR	BOSTON	MA	02215	042510564	501(c)(3)	11186	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	FINANCE
FRONTIER SCIENCE AND TECHNOLOGY
P O BOX 983027		BOSTON	MA	022983027	161056814	501(c)(3)	124565	0	N/A	N/A	HVTN LABORATORY PROGRAM
FRONTIER SCIENCE AND TECHNOLOGY
P O BOX 983027		BOSTON	MA	022983027	161056814	501(c)(3)	48960	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HVTN
FRONTIER SCIENCE AND TECHNOLOGY
P O BOX 983027		BOSTON	MA	022983027	161056814	501(c)(3)	92708	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HIV PR
FRONTIER SCIENCE AND TECHNOLOGY
P O BOX 983027		BOSTON	MA	022983027	161056814	501(c)(3)	35874	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- MICRO
GENERAL HOSPITAL CORPORATION DBA
P O BOX 414876		BOSTON	MA	022414876	042697983	501(c)(3)	19780	0	N/A	N/A	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F	RESEARCH FINANCE
GENERAL HOSPITAL CORPORATION DBA
P O BOX 3829	BANK OF AMERICA NA	BOSTON	MA	022413829	042697983	501(c)(3)	393163	0	N/A	N/A	EXPANSION OF CARDIAC AND HEMATOPOIETIC PREGENITORS BY WN	RESEARCH FINANCE
GENERAL HOSPITAL CORPORATION DBA
P O BOX 3829	BANK OF AMERICA NA	BOSTON	MA	022413829	042697983	501(c)(3)	43074	0	N/A	N/A	MEASUREMENT OF CANCER-ASSOCIATED BIOMARKER PROTEINS IN C	RESEARCH FINANCE
GROUP HEALTH COOPERATIVE
P O BOX 34587		SEATTLE	WA	981249990	910511770	501(c)(3)	12528	0	N/A	N/A	COLON CANCER PATHWAYS- HYPERPLASTICS POLYPS AND ADENOMA
GROUP HEALTH COOPERATIVE
P O BOX 34587		SEATTLE	WA	981249990	910511770	501(c)(3)	6733	0	N/A	N/A	MODELING US PROSTATE CANCER TRENDS- PSA/ TREATMENT & RAC
GROUP HEALTH COOPERATIVE
P O BOX 34587		SEATTLE	WA	981249990	910511770	501(c)(3)	28515	0	N/A	N/A	PREVENTION OF OVARIAN CANCER IN WOMEN PARTICIPATING IN M	ATTN CASH DESK
GROUP HEALTH COOPERATIVE
P O BOX 34587		SEATTLE	WA	981249990	910511770	501(c)(3)	143185	0	N/A	N/A	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F
GROUP HEALTH COOPERATIVE
P O BOX 34587		SEATTLE	WA	981249990	910511770	501(c)(3)	159961	0	N/A	N/A	ACCEPTANCE AND COMMITMENT THERAPY FOR SMOKING CESSATI
H LEE MOFFITT CANCER CENTER
122902 MAGNOLIA DRIVE		TAMPA	FL	33612	593238634	501(c)(3)	34612	0	N/A	N/A	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD	MRC-RESADIM
H LEE MOFFITT CANCER CENTER
122902 MAGNOLIA DRIVE		TAMPA	FL	33612	593238634	501(c)(3)	55205	0	N/A	N/A	IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC	MRC-RESADIM
HARBORVIEW MEDICAL CENTER
325 NINTH AVE	BOX 359750	SEATTLE	WA	98104	911631806	County Med Ctr	39448	0	N/A	N/A	LIVESTRONG SURVIVORSHIP CENTER OF EXCELLENCE
HEKTOEN INSTITUTE FOR MED RESEARCH LLC
2240 W OGDEN AVE		CHICAGO	IL	606129982	362244897	501(c)(3)	103957	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HIV PR
HEMATOLOGICS INC
P O BOX 24712		SEATTLE	WA	98124	911685196		56100	0	N/A	N/A	BRIDGE FUNDING- MOLECULAR ASSESSMENT OF MINIMAL RISK DIS
HENRY M JACKSON FOUNDATION FOR THE
1401 ROCKVILLE PIKE SUITE 600		ROCKVILLE	MD	20852	521317896	501(c)(3)	210196	0	N/A	N/A	HVTN LABORATORY PROGRAM
IMMUNE DESIGN CORP
1124 COLUMBIA ST	SUITE 700	SEATTLE	WA	98104	262007174		16668	0	N/A	N/A	WASHINGTON VACCINE ALLIANCE
INDIANA UNIVERSITY
P O BOX 66057		INDIANAPOLIS	IN	462666057	356001673	University	265622	0	N/A	N/A	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F	FINANCIAL MANAGEMENT SUPPORT
INFECTIOUS DISEASE CNSLTNTS MD PA DBA
1701 N MILLS AVE		ORLANDO	FL	32803	591634257		902898	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
INSTITUTE FOR SYSTEMS BIOLOGY
1441 NORTH 34TH STREET		SEATTLE	WA	981038904	912003593	501(c)(3)	750341	0	N/A	N/A	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF
JOHNS HOPKINS UNIVERSITY
12529 COLLECTIONS CENTER DRIVE		CHICAGO	IL	60693	520595110	501(c)(3)	110838	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	C/O BANK OF AMERICA
JOHNS HOPKINS UNIVERSITY
12529 COLLECTIONS CENTER DRIVE		CHICAGO	IL	60693	520595110	501(c)(3)	109846	0	N/A	N/A	BIOCONDUCTOR- AN OPEN COMPUTING RESOURCE FOR GENOMICS	C/O BANK OF AMERICA
JOHNS HOPKINS UNIVERSITY
12529 COLLECTIONS CENTER DRIVE		CHICAGO	IL	60693	520595110	501(c)(3)	12861	0	N/A	N/A	GENETIC PROGRESSION OF PANCREATIC MUCINOUS CYSTIC NEOPLA	C/O BANK OF AMERICA
KAISER FOUNDATION HOSPITALS
1800 HARRISON STREET	16TH FLOOR	OAKLAND	CA	946123433	941105628	501(c)(3)	143728	0	N/A	N/A	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT	KAISER FOUNDATION RESEARCH INSTITUTE
KAISER FOUNDATION HOSPITALS
1800 HARRISON STREET	16TH FLOOR	OAKLAND	CA	946123433	941105628	501(c)(3)	156657	0	N/A	N/A	CORE ASSAYS MRLI - W1 W3	KAISER FOUNDATION RESEARCH INSTITUTE
KAISER FOUNDATION HOSPITALS
1800 HARRISON STREET	16TH FLOOR	OAKLAND	CA	946123433	941105628	501(c)(3)	206642	0	N/A	N/A	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F	KAISER FOUNDATION RESEARCH INSTITUTE
KAISER FOUNDATION HOSPITALS
1800 HARRISON STREET	16TH FLOOR	OAKLAND	CA	946123433	941105628	501(c)(3)	62181	0	N/A	N/A	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI	KAISER FOUNDATION RESEARCH INSTITUTE
KAISER FOUNDATION HOSPITALS
1800 HARRISON STREET	16TH FLOOR	OAKLAND	CA	946123433	941105628	501(c)(3)	17459	0	N/A	N/A	UNDERSTANDING AND PREVENTING BREAST CANCER DISPARITIES I	KAISER FOUNDATION RESEARCH INSTITUTE
LABKEY CORPORATION
2226 EASTLAKE AVE E	Suite 101	SEATTLE	WA	98102	208266728	501(c)(3)	60265	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HVTN
LABKEY CORPORATION
2226 EASTLAKE AVE E	Suite 101	SEATTLE	WA	98102	208266728	501(c)(3)	10136	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- MICRO
LABKEY CORPORATION
2226 EASTLAKE AVE E	Suite 101	SEATTLE	WA	98102	208266728	501(c)(3)	136078	0	N/A	N/A	CROSS-SPECIES HIV IMMUNOLOGY STATISTICS AND DATA CENTER
LABKEY CORPORATION
2226 EASTLAKE AVE E	Suite 101	SEATTLE	WA	98102	208266728	501(c)(3)	21314	0	N/A	N/A	CABIG-ISRCE- IN SILICO RESEARCH CENTERS OF EXCELLENCE
LOUISIANA STATE UNIVERSITY HEALTH
433 BOLIVAR ST		NEW ORLEANS	LA	701122223	726087770		36136	0	N/A	N/A	IMMUNIZATION OF ORAL MUCOSA FOR INDUCTION OF RECTAL AND	INTERLIBRARY LOAN
MAGEE WOMEN'S RESEARCH INSTITUTE
3339 WARD STREET		PITTSBURGH	PA	15213	251462312	501(c)(3)	7514	0	N/A	N/A	HVTN LABORATORY PROGRAM	OFFICE OF RESEARCH ADMINISTRATION
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
77 MASSACHUSETTS AVENUE	NE49-3077	CAMBRIDGE	MA	02139	042103594	501(c)(3)	60636	0	N/A	N/A	HVTN LABORATORY PROGRAM	CASHIER'S OFFICE
MAYO CLINIC ROCHESTER DBA
P O BOX 4008		ROCHESTER	MN	559034008	416011702	501(c)(3)	121798	0	N/A	N/A	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI	REMIT PROCESSING
MEDICAL COLLEGE OF WISCONSIN INC
8701 WATERTOWN PLANK RD	P O BOX 26509	MILWAUKEE	WI	532260509	390806261	501(c)(3)	14960	0	N/A	N/A	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD	FINANCE & ADMINISTRATION
MEDICAL COLLEGE OF WISCONSIN INC
8701 WATERTOWN PLANK RD	P O BOX 26509	MILWAUKEE	WI	532260509	390806261	501(c)(3)	13288	0	N/A	N/A	HEMATOPOPIETIC STEM CELL TRANSPLANTATION	FINANCE & ADMINISTRATION
MEDICAL COLLEGE OF WISCONSIN INC
8701 WATERTOWN PLANK RD		MILWAUKEE	WI	53226	390806261	501(c)(3)	24722	0	N/A	N/A	HEMATOPOIETIC STEM CELL AND CORD BLOOD TRANSPLANTATION	DEPT OF PEDIATRICS M3018
MEDICAL UNIVERSITY OF SOUTH CAROLINA
19 HAGOOD AVE	SUITE 303 MSC 804	CHARLESTON	SC	294258040	576000722		85103	0	N/A	N/A	RADIATION DOSE-DEPENDENT INTERVENTIONS	CASHIERS OFFICE
MEDICAL UNIVERSITY OF SOUTH CAROLINA
19 HAGOOD AVE	SUITE 303 MSC 804	CHARLESTON	SC	294258040	576000722		65221	0	N/A	N/A	HVTN LABORATORY PROGRAM	CASHIERS OFFICE
MIRIAM HOSPITAL
593 EDDY STREET	RES ADMIN-ALDRICH 3	PROVIDENCE	RI	02903	050258905	501(c)(3)	28080	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	RHODE ISLAND HOSPITAL
MOUNT SINAI SCHOOL OF MEDICINE
ONE GUSTAVE L LEVY PLACE BOX 1410		NEW YORK	NY	100296574	136171197	501(c)(3)	11631	0	N/A	N/A	A POOLED ANALYSIS OF RISK FACTORS OF SMALL INTESTINE CAN
NATIONAL INSTITUTES OF HEALTH
31 CENTER DRIVE ROOM B1B11	MSC 2052	BETHESDA	MD	208922052	520858115	NATIONAL INSTITUTES	125000	0	N/A	N/A	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF	OFM DEFS GRANT ACCOUNTING BRANCH
NATIONAL JEWISH HEALTH
1400 JACKSON STREET	ROOM M213	DENVER	CO	80206	742044647	501(c)(3)	6803	0	N/A	N/A	A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L
NEW YORK BLOOD CENTER INC
1200 PROSPECT AVENUE		WESTBURY	NY	11590	131949477	501(c)(3)	985166	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
P O BOX 415026		BOSTON	MA	022415026	135562309		108598	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	ANTHONY MARSICANO-SPONSORED PROGRAMS
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
P O BOX 415026		BOSTON	MA	022415026	135562309		178833	0	N/A	N/A	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF	ANTHONY MARSICANO-SPONSORED PROGRAMS
NORTHEASTERN UNIVERSITY
360 HUNTINGTON AVE		BOSTON	MA	02115	041679980	501(c)(3)	45828	0	N/A	N/A	NOVEL CULTIVATION METHODS FOR THE DOMESTICATION OF VAGIN
NORTHWEST COMMUNITIES EDUCATION CENTER
P O BOX 800		GRANGER	WA	98932	910969818	501(c)(3)	26073	0	N/A	N/A	PARTNERSHIP FOR A HISPANIC DIABETES PREVENTION PROGRAM	KDNA RADIO STATION
NORTHWEST PORTLAND AREA INDIAN
2121 SW BROADWAY	STE 300	PORTLAND	OR	97201	930718154	501(c)(3)	6595	0	N/A	N/A	A MULTI-STATE STUDY OF CANCER TREATMENT AND OUTCOME AMON
NY CITY DEPT OF HLTH AND MENTAL HYGIENE
42-09 28TH STREET WS 21-127		LONG ISLAND CITY	NY	11101	136400434	501(c)(3)	757632	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HIV PR	ROSSANA VOLPE
OHIO STATE UNIVERSITY RSRCH FOUNDATION
1960 KENNY RD	4TH FLOOR	COLUMBUS	OH	432101063	316401599	501(c)(3)	19676	0	N/A	N/A	EPIDEMIOLOGY OF PUTATIVE GENETIC GENETIC VARIANTS IN THE	ACCOUNTING DEPT
OHIO STATE UNIVERSITY RSRCH FOUNDATION
1960 KENNY RD	4TH FLOOR	COLUMBUS	OH	432101063	316401599	501(c)(3)	16661	0	N/A	N/A	GWAS OF HORMONE TREATMENT AND CVD AND METABOLIC OUTCOMES	ACCOUNTING DEPT
OREGON HEALTH & SCIENCE UNIVERSITY
2525 SW FIRST AVENUE	SUITE 220	PORTLAND	OR	97201	931176109	University	1425170	0	N/A	N/A	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF	SPONSORED PROJECTS ADMINISTRATION
OREGON HEALTH & SCIENCE UNIVERSITY
2525 SW FIRST AVENUE	SUITE 220	PORTLAND	OR	97201	931176109	University	1371527	0	N/A	N/A	IMMUNE CORRELATES OF PROTECTION AGAINST HIV AND SIV INFE	SPONSORED PROJECTS ADMINISTRATION
OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW SAM JACKSON PARK ROAD		PORTLAND	OR	97239	931176109	University	15400	0	N/A	N/A	THE PACIFIC NORTHWEST PROSTATE CANCER SPORE
OREGON HEALTH & SCIENCE UNIVERSITY
0690 SW BANCROFT ST	MAILCODE L106SPA	PORTLAND	OR	97239	931176109	University	513586	0	N/A	N/A	IMMUNIZATION OF ORAL MUCOSA FOR INDUCTION OF RECTAL AND	SPONSORED PROJECTS ADMINSTRATION
OREGON UNIVERSITY SYSTEM
5219 UNIVERSITY OF OREGON		EUGENE	OR	974035219	936001786	University	497587	0	N/A	N/A	TILLING THE ZEBRAFISH GENOME- A REVERSE GENETICS APPROAC	OFFICE OF RESEARCH SERVICES AND ADMINISTRATION
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
P O BOX 415649		BOSTON	MA	022415649	042103580	501(c)(3)	129491	0	N/A	N/A	GENOME-WIDE PROFILING OF HISTONE VARIANTS IN DROSOPHILA
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
P O BOX 415649		BOSTON	MA	022415649	042103580	501(c)(3)	24073	0	N/A	N/A	STATISTICAL METHODS FOR PROSPECTIVE EVALUATION OF BIOMAR
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
P O BOX 415649		BOSTON	MA	022415649	042103580	501(c)(3)	8132	0	N/A	N/A	GENOME-WIDE PROFILINGOF HISTONE VARIANTS IN DROSOPHILA A
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
P O BOX 415649		BOSTON	MA	022415649	042103580	501(c)(3)	26182	0	N/A	N/A	EPIGENOMIC PROFILING OF HISTONE TURNOVER KINETICS IN MAM
PROVIDENCE HEALTH & SERVICES-WASHINGTON
3200 PROVIDENCE DRIVE		ANCHORAGE	AK	99508	920016429	Hospital	41114	0	N/A	N/A	LIVESTRONG SURVIVORSHIP CENTER OF EXCELLENCE
PUBLIC HEALTH FOUNDATION ENTERPRISES INC
12801 CROSSROADS PARKWAY SOUTH	Suite 200	CITY OF INDUSTRY	CA	91746	952557063	501(c)(3)	1050110	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
PUBLIC HEALTH FOUNDATION ENTERPRISES INC
12801 CROSSROADS PARKWAY SOUTH	Suite 200	CITY OF INDUSTRY	CA	91746	952557063	501(c)(3)	45693	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
PUGET SOUND BLOOD CENTER AND PROGRAM
921 TERRY AVENUE		SEATTLE	WA	981041256	911019655	501(c)(3)	171210	0	N/A	N/A	THERAPIES FOR HEMATOPOIETIC SYNDROME, BONE MARROW STROMA
PUGET SOUND BLOOD CENTER AND PROGRAM
921 TERRY AVENUE		SEATTLE	WA	981041256	911019655	501(c)(3)	44763	0	N/A	N/A	CORE CENTER OF EXCELLENCE IN HEMATOLOGY
REGENTS OF THE UNIV OF CALIFORNIA
BOX 0897		SAN FRANCISCO	CA	94143	946036493	University	76274	0	N/A	N/A	MECHANISM-BASED CLASSIFICATION AND TARGETING OF CASTRATI	ACCOUNTING OFFICE - EMF
REGENTS OF THE UNIV OF CALIFORNIA
BOX 0897		SAN FRANCISCO	CA	94143	946036493	University	7905	0	N/A	N/A	MODELING PROSTATE CANCER CONTROL- PREVENTION/ SCREENING	ACCOUNTING OFFICE - EMF
REGENTS OF THE UNIVERSITY
ACCOUNTING OFFICE	SUITE 1400	IRVINE	CA	926971050	952226406	University	65036	0	N/A	N/A	EARLY AND REINFECTION IN HIGH RISK WOMEN	BIOLOGICAL SCIENCES III
REGENTS OF THE UNIVERSITY OF CA AT LOS
405 HILGARD AVENUE	1125 MURPHY HALL BOX 951432	LOS ANGELES	CA	900959000	956006143	University	78658	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	REMITTANCE CENTER
REGENTS OF THE UNIVERSITY OF CA AT LOS
405 HILGARD AVENUE	1125 MURPHY HALL BOX 951432	LOS ANGELES	CA	900959000	956006143	University	37945	0	N/A	N/A	EVALUATION OF A HEPATITIS B OUTREACH INTERVENTION FOR CA	REMITTANCE CENTER
REGENTS OF THE UNIVERSITY OF CA AT LOS
405 HILGARD AVENUE	1125 MURPHY HALL BOX 951432	LOS ANGELES	CA	900959000	956006143	University	148363	0	N/A	N/A	MARKERS OF B-CELL STIMULATION AS POTENTIAL PREDICTORS OF	REMITTANCE CENTER
REGENTS OF THE UNIVERSITY OF CA AT LOS
405 HILGARD AVENUE	1125 MURPHY HALL BOX 951432	LOS ANGELES	CA	900959000	956006143	University	22227	0	N/A	N/A	GWAS OF HORMONE TREATMENT AND CVD AND METABOLIC OUTCOMES	REMITTANCE CENTER
REGENTS OF THE UNIVERSITY OF CALIFORNIA
P O BOX 989062		WEST SACRAMENTO	CA	957989062	946036494	University	92237	0	N/A	N/A	A PROSPECTIVE STUDY OF COLORECTAL CANCER- ONE-CARBON ME	CASHIER'S OFFICE
REGENTS OF THE UNIVERSITY OF CALIFORNIA
P O BOX 989062		WEST SACRAMENTO	CA	957989062	946036494	University	38813	0	N/A	N/A	STATISTICAL METHODS FOR INTEGRATIVE ANALYSIS OF GENOMICS	CASHIER'S OFFICE
REGENTS OF THE UNIVERSITY OF CALIFORNIA
P O BOX 989062		WEST SACRAMENTO	CA	957989062	946036494	University	172411	0	N/A	N/A	BISPECIFIC ANTIBODY ENGINEERING FOR AML RIT	CASHIER'S OFFICE
REGENTS OF THE UNIVERSITY OF MICHIGAN
BOX 223131		PITTSBURGH	PA	152512131	386006309	University	201571	0	N/A	N/A	MODELING PROSTATE CANCER CONTROL- PREVENTION/ SCREENING
REGENTS OF THE UNIVERSITY OF MINNESOTA
P O BOX 1450	NW 5957	MINNEAPOLIS	MN	554855957	416007513	University	123125	0	N/A	N/A	CORE ASSAYS MRLI - W1 W3
REGENTS OF THE UNIVERSITY OF MINNESOTA
P O BOX 1450	NW 5957	MINNEAPOLIS	MN	554855957	416007513	University	87590	0	N/A	N/A	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F
REGENTS OF THE UNIVERSITY OF MINNESOTA
P O BOX 1450	NW 5957	MINNEAPOLIS	MN	554855957	416007513	University	9418	0	N/A	N/A	IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC
REGENTS OF THE UNIVERSITY OF MINNESOTA
P O BOX 1450	NW 5957	MINNEAPOLIS	MN	554855957	416007513	University	25169	0	N/A	N/A	INTERGRATED SENSOR TECHNOLOGY FOR REAL-TIME RECORDING OF
REGENTS OF THE UNIVERSITY OF MINNESOTA
P O BOX 1450	NW 5957	MINNEAPOLIS	MN	554855957	416007513	University	51499	0	N/A	N/A	METABOLIC SYNDROME FOLLOWING TRANSPLANT FOR LEUKEMIA
REGENTS OF UNIVERSITY OF COLORADO
DEPARTMENT 238		DENVER	CO	802910238	846000555	University	186819	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	OFFICE OF GRANTS & CONTRACTS-F428
REGENTS OF UNIVERSITY OF COLORADO
DEPARTMENT 238		DENVER	CO	802910238	846000555	University	45639	0	N/A	N/A	VITAMIN D AND PROSTATE CANCER- BIOMARKERS AND GENETIC VA	OFFICE OF GRANTS & CONTRACTS-F428
RESEARCH FOUNDATION OF STATE UNIVERSITY
P O BOX 9		ALBANY	NY	122010009	141368361	501(c)(3)	63436	0	N/A	N/A	POPULATION PHARMACOKINETICS / PHARMACODYNAMICS IN NONABL	CASH RECEIPT DEPARTMENT
RUSH UNIVERSITY MEDICAL CENTER
1700 WEST VAN BUREN	ROOM 277	CHICAGO	IL	60612	362174823	501(c)(3)	12945	0	N/A	N/A	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM	FUND ACCOUNTING
SAINT JUDE CHILDRENS RESEARCH HOSPITAL
P O BOX 1000	DEPT 949	MEMPHIS	TN	381480949	620646012	501(c)(3)	18899	0	N/A	N/A	LATE EFFECTS OF TREATMENT IN WILMS-TUMOR SURVIVORS AND O
SAINT LOUIS UNIVERSITY
3700 WEST PINE MALL	FUSZ MEMORIAL HALL SUITE 357	SAINT LOUIS	MO	63108	430654872	501(c)(3)	12794	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
307 WESTLAKE AVE N	SUITE 500	SEATTLE	WA	981095219	910961784	501(c)(3)	179138	0	N/A	N/A	IMMUNIZATION OF ORAL MUCOSA FOR INDUCTION OF RECTAL AND
SEATTLE CHILDREN'S
P O BOX 34935	DEPT 736	SEATTLE	WA	981241936	910564748	501(c)(3)	7369	0	N/A	N/A	LIVESTRONG SURVIVORSHIP CENTER OF EXCELLENCE
SEATTLE CHILDREN'S
P O BOX 34935	DEPT 736	SEATTLE	WA	981241936	910564748	501(c)(3)	90319	0	N/A	N/A	STEM CELL TRANSPLANTATION- BASIC/CLINICAL RESEARCH
SEATTLE CHILDREN'S
P O BOX 24728		SEATTLE	WA	981240728	910564748	501(c)(3)	97885	0	N/A	N/A	FUNCTION OF HUMAN AND MOUSE BETA-GLOBIN LOCUS CONTROL RE
SEATTLE CHILDREN'S
P O BOX 24728		SEATTLE	WA	981240728	910564748	501(c)(3)	27690	0	N/A	N/A	PREGNANCY, MICROCHIMERISM, AND AUTOIMMUNE DISEASE
SEATTLE CHILDREN'S
P O BOX 24728		SEATTLE	WA	981240728	910564748	501(c)(3)	143530	0	N/A	N/A	CANCER CENTER SUPPORT GRANT (COMPREHENSIVE)
SEATTLE CHILDREN'S
P O BOX 24728		SEATTLE	WA	981240728	910564748	501(c)(3)	50890	0	N/A	N/A	ACTIVATION AND SILENCING OF GENE EXPRESSION DURING HEMAT
SEATTLE CHILDREN'S
P O BOX 24728		SEATTLE	WA	981240728	910564748	501(c)(3)	87919	0	N/A	N/A	TARGETED THERAPY OF ALL WITH GENE-MODIFIED CENTRAL MEMOR
SEATTLE CHILDREN'S
P O BOX 24728		SEATTLE	WA	981240728	910564748	501(c)(3)	33020	0	N/A	N/A	TOWARDS A MODEL OF FANCONI ANEMIA
SEATTLE CHILDREN'S
P O BOX 34935	DEPT 736	SEATTLE	WA	981241936	910564748	501(c)(3)	21330	0	N/A	N/A	DIGITAL DNASEL MAPPING AND FOOTPRINTING OF THE MOUSE GEN
SEATTLE CHILDREN'S
P O BOX 34935	DEPT 736	SEATTLE	WA	981241936	910564748	501(c)(3)	115368	0	N/A	N/A	METABOLIC SYNDROME FOLLOWING TRANSPLANT FOR LEUKEMIA
SEATTLE CHILDREN'S
P O BOX 24728		SEATTLE	WA	981240728	910564748	501(c)(3)	31899	0	N/A	N/A	CONSORTIUM BIOSPECIMEN PROGRAM
SEATTLE CHILDREN'S
P O BOX 24728		SEATTLE	WA	981240728	910564748	501(c)(3)	21255	0	N/A	N/A	A COMPREHENSIVE CATALOGUE OF MOUSE DNASEI HYPERSENSITIVE
SEATTLE INST FOR BIOMED & CLINICAL RES
1660 SOUTH COLUMBIAN WAY	S-151F	SEATTLE	WA	98108	911452438	501(c)(3)	207761	0	N/A	N/A	THE PACIFIC NORTHWEST PROSTATE CANCER SPORE
SEATTLE INST FOR BIOMED & CLINICAL RES
1660 SOUTH COLUMBIAN WAY	S-151F	SEATTLE	WA	98108	911452438	501(c)(3)	36970	0	N/A	N/A	IN VIVO EFFECTS OF SULFORAPHANE SUPPLEMENTATION ON NORMA
SLOAN KETTERING INSTITUTE FOR
P O BOX 26338	GENERAL POST OFFICE	NEW YORK	NY	10087	131624182	501(c)(3)	26131	0	N/A	N/A	GENOME-WIDE ASSOCIATION STUDY OF ENDOMETRIAL CANCER	MSKCC FINANCE
SLOAN KETTERING INSTITUTE FOR
P O BOX 26338	GENERAL POST OFFICE	NEW YORK	NY	10087	131624182	501(c)(3)	63504	0	N/A	N/A	HEMATOPOPIETIC STEM CELL TRANSPLANTATION	MSKCC FINANCE
SLOAN KETTERING INSTITUTE FOR
P O BOX 26338	GENERAL POST OFFICE	NEW YORK	NY	10087	131624182	501(c)(3)	229160	0	N/A	N/A	HEMATOPOIETIC STEM CELL AND CORD BLOOD TRANSPLANTATION	MSKCC FINANCE
SUNNYSIDE COMMUNITY HOSPITAL INC
P O BOX 719		SUNNYSIDE	WA	98944	911286274	501(c)(3)	56658	0	N/A	N/A	PARTNERSHIP FOR A HISPANIC DIABETES PREVENTION PROGRAM
SWEDISH HEALTH SERVICES
P O BOX 94085		SEATTLE	WA	981249485	910433740	501(c)(3)	10765	0	N/A	N/A	PREVENTION OF OVARIAN CANCER IN WOMEN PARTICIPATING IN M	SWEDISH HEALTH SERVICES GRANTS
TORREY PINES INST FOR MOLECULAR STUDIES
11350 SW VILLAGE PARKWAY		PORT ST LUCIE	FL	34987	330319501	501(c)(3)	165937	0	N/A	N/A	IDENTIFICATION OF T CELL-DEFINED ANTIGENS IN OVARIAN CAN
TRANSLATIONAL GENOMICS RES INSTITUTE
445 N 5TH ST	SUITE 600	PHOENIX	AZ	85004	753065445	501(c)(3)	26253	0	N/A	N/A	GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN C
TRANSLATIONAL GENOMICS RES INSTITUTE
445 N 5TH ST	SUITE 600	PHOENIX	AZ	85004	753065445	501(c)(3)	55174	0	N/A	N/A	A PROSPECTIVE STUDY OF COLORECTAL CANCER- ONE-CARBON ME
TRANSLATIONAL GENOMICS RES INSTITUTE
445 N 5TH ST	SUITE 600	PHOENIX	AZ	85004	753065445	501(c)(3)	90306	0	N/A	N/A	EPIDEMIOLOGY OF PUTATIVE GENETIC GENETIC VARIANTS IN THE
TRANSLATIONAL GENOMICS RES INSTITUTE
445 N 5TH ST	SUITE 600	PHOENIX	AZ	85004	753065445	501(c)(3)	716287	0	N/A	N/A	INFLAMMATION AND THROMBOSIS GENE PATHWAYS AND CARDIOVASC
TRANSLATIONAL GENOMICS RES INSTITUTE
445 N 5TH ST	SUITE 600	PHOENIX	AZ	85004	753065445	501(c)(3)	360551	0	N/A	N/A	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR
TRANSLATIONAL GENOMICS RES INSTITUTE
445 N 5TH ST	SUITE 600	PHOENIX	AZ	85004	753065445	501(c)(3)	162204	0	N/A	N/A	EPIDEMIOLOGY OF PUTATIVE GENUINE GENETIC VARIANT- THE WO
TRUSTEES OF COLUMBIA UNIVERSITY IN
P O BOX 29789		NEW YORK	NY	100879789	135598093	501(c)(3)	1592938	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	CU RESEARCH ADMINISTRATION
TRUSTEES OF THE UNIVERSITY OF
P O BOX 785541		PHILADELPHIA	PA	191785541	231352685	501(c)(3)	18023	0	N/A	N/A	TREC COORDINATION CENTER
TRUSTEES OF THE UNIVERSITY OF
P O BOX 785541		PHILADELPHIA	PA	191785541	231352685	501(c)(3)	1462383	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
TRUSTEES OF THE UNIVERSITY OF
P O BOX 785541		PHILADELPHIA	PA	191785541	231352685	501(c)(3)	53057	0	N/A	N/A	GENOME-WIDE ASSOCIATION STUDY OF ENDOMETRIAL CANCER
UNIVERSITY OF ALABAMA BIRMINGHAM
1530 THIRD AVENUE SOUTH	AB 990	BIRMINGHAM	AL	352940109	636005396	University	583202	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	GRANTS AND CONTRACTS ACCOUNTING
UNIVERSITY OF GEORGIA RESEARCH
475 N LUMPKIN STREET		Athens	GA	30602	581353149	501(c)(3)	5168	0	N/A	N/A	FUNCTIONAL METHODS FOR RADIATION EXPOSURE AND BIOMARKER	UGA CONTRACTS & GRANTS C/O PAM RAY
UNIVERSITY OF HAWAII
2530 DOLE STREET	SAKAMAKI D200	HONOLULU	HI	96822	996000354	University	117148	0	N/A	N/A	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR	OFFICE OF RESEARCH SERVICES
UNIVERSITY OF IDAHO
P O BOX 443020		MOSCOW	ID	838443020	826000945	University	7090	0	N/A	N/A	WASHINGTON VACCINE ALLIANCE	OFFICE OF SPONSORED PROGRAMS
UNIVERSITY OF IDAHO
P O BOX 443020		MOSCOW	ID	838443020	826000945	University	113425	0	N/A	N/A	WASHINGTON VACCINE ALLIANCE	OFFICE OF SPONSORED PROGRAMS
UNIVERSITY OF NEW MEXICO
1 UNIVERSITY OF NEW MEXICO	MSC09 5225	ALBUQUERQUE	NM	871310001	856000642	University	51671	0	N/A	N/A	REDUCING OBESITY AT THE WORKPLACE- A RANDOMIZED TRIAL	HSC CONTRACT AND GRANT ACCOUNTING
UNIVERSITY OF NEW MEXICO
1 UNIVERSITY OF NEW MEXICO	MSC09 5225	ALBUQUERQUE	NM	871310001	856000642	University	39700	0	N/A	N/A	TREC- MECHANISMS OF ENERGY BALANCE AND CANCER PREVENTION	HSC CONTRACT AND GRANT ACCOUNTING
UNIVERSITY OF NEW MEXICO
1 UNIVERSITY OF NEW MEXICO	MSC09 5225	ALBUQUERQUE	NM	871310001	856000642	University	79375	0	N/A	N/A	TREC COORDINATION CENTER	HSC CONTRACT AND GRANT ACCOUNTING
UNIVERSITY OF NEW MEXICO
1 UNIVERSITY OF NEW MEXICO	MSC09 5225	ALBUQUERQUE	NM	871310001	856000642	University	283549	0	N/A	N/A	UNDERSTANDING AND PREVENTING BREAST CANCER DISPARITIES I	HSC CONTRACT AND GRANT ACCOUNTING
UNIVERSITY OF NO CAROLINA AT CHARLOTTE
9201 UNIVERSITY CITY BOULEVARD		CHARLOTTE	NC	282230001	560791228	University	98266	0	N/A	N/A	STATISTICAL METHODS IN HIV VACCINE EFFICACY TRIALS	FINANCIAL SERVICES/SPONSORED PROGRAMS
UNIVERSITY OF NORTH CAROLINA
P O BOX 402420		ATLANTA	GA	303842420	566001393	University	244549	0	N/A	N/A	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT	OFFICE OF SPONSORED RESEARCH
UNIVERSITY OF NORTH CAROLINA
P O BOX 402420		ATLANTA	GA	303842420	566001393	University	23315	0	N/A	N/A	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI	OFFICE OF SPONSORED RESEARCH
UNIVERSITY OF NORTH CAROLINA
P O BOX 402420		ATLANTA	GA	303842420	566001393	University	26613	0	N/A	N/A	MEASUREMENT OF CANCER-ASSOCIATED BIOMARKER PROTEINS IN C	OFFICE OF SPONSORED RESEARCH
UNIVERSITY OF NORTH CAROLINA
P O BOX 402420		ATLANTA	GA	303842420	566001393	University	51675	0	N/A	N/A	STATISTICAL METHODS IN HIV VACCINE EFFICACY TRIALS	OFFICE OF SPONSORED RESEARCH
UNIVERSITY OF PITTSBURGH
3109 CATHEDRAL OF LEARNING		PITTSBURGH	PA	15260	250965591	501(c)(3)	15359	0	N/A	N/A	HVTN LABORATORY PROGRAM	OFFICE OF RES/COST ACCTG
UNIVERSITY OF PITTSBURGH
P O BOX 371220		PITTSBURGH	PA	152517220	250965591	501(c)(3)	17928	0	N/A	N/A	EPIDEMIOLOGY OF PUTATIVE GENETIC GENETIC VARIANTS IN THE
UNIVERSITY OF PITTSBURGH
3109 CATHEDRAL OF LEARNING		PITTSBURGH	PA	15260	250965591	501(c)(3)	24793	0	N/A	N/A	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR	OFFICE OF RES/COST ACCTG
UNIVERSITY OF PITTSBURGH
3109 CATHEDRAL OF LEARNING		PITTSBURGH	PA	15260	250965591	501(c)(3)	16424	0	N/A	N/A	GWAS OF HORMONE TREATMENT AND CVD AND METABOLIC OUTCOMES	OFFICE OF RES/COST ACCTG
UNIVERSITY OF PITTSBURGH
642 B SCAIFE HALL	3550 TERRACE STREET	PITTSBURGH	PA	15261	250965591	501(c)(3)	15150	0	N/A	N/A	A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L
UNIVERSITY OF ROCHESTER
910 GENESEE STREET	SUITE 200	ROCHESTER	NY	146113847	160743209		1160817	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	OFFICE OF RESEARCH ACCT & COST STANDARDS
UNIVERSITY OF ROCHESTER
910 GENESEE STREET	SUITE 200	ROCHESTER	NY	146113847	160743209		181772	0	N/A	N/A	THE PATHOGENESIS OF FMD- FACIOSCAPULOHUMERAL MUSCULAR	OFFICE OF RESEARCH ACCT & COST STANDARDS
UNIVERSITY OF SOUTHERN CALIFORNIA
SPONSORED PROJECTS ACCOUNTING		LOS ANGELES	CA	900742095	951642394		17198	0	N/A	N/A	BIOLOGY AND PROGNOSTIC IMPLICATIONS OF FLT3 MUTATIONS IN	FILE NO 52095
UNIVERSITY OF SOUTHERN CALIFORNIA
SPONSORED PROJECTS ACCOUNTING		LOS ANGELES	CA	900742095	951642394		20599	0	N/A	N/A	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI	FILE NO 52095
UNIVERSITY OF SOUTHERN CALIFORNIA
SPONSORED PROJECTS ACCOUNTING		LOS ANGELES	CA	900742095	951642394		207595	0	N/A	N/A	IMPROVING EARLY DETECTION OF BREAST CANCER WITH A BLOOD	FILE NO 52095
UNIVERSITY OF SOUTHERN CALIFORNIA
SPONSORED PROJECTS ACCOUNTING		LOS ANGELES	CA	900742095	951642394		21068	0	N/A	N/A	IRF8 AS A BIOMARKER OF AGING, MALIGNANT TRANSFORMATION,	FILE NO 52095
UNIVERSITY OF SOUTHERN CALIFORNIA
SPONSORED PROJECTS ACCOUNTING		LOS ANGELES	CA	900742095	951642394		5445	0	N/A	N/A	THE BREAST CANCER BIOMARKER DISCOVERY CONSORTIUM- PHASE	FILE NO 52095
UNIVERSITY OF SOUTHERN CALIFORNIA
SPONSORED PROJECTS ACCOUNTING		LOS ANGELES	CA	900742095	951642394		70556	0	N/A	N/A	BIOMARKER FOR RISK IDENTIFICATION AND RISK-BASED THERAPY	FILE NO 52095
UNIVERSITY OF TEXAS HEALTH SCIENCES
P O BOX 203382		HOUSTON	TX	772163382	741761309	University	34049	0	N/A	N/A	PROSTAGLANDIN SYNTHESIS, GENETICS AND COLORECTAL CANCER	FINANCIAL ADMINSTRATIVE SUPPORT
UNIVERSITY OF TEXAS HEALTH SCIENCES
P O BOX 203382		HOUSTON	TX	772163382	741761309	University	9671	0	N/A	N/A	PREGNANCY, MICROCHIMERISM, AND AUTOIMMUNE DISEASE	FINANCIAL ADMINSTRATIVE SUPPORT
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL
P O BOX 841765		DALLAS	TX	752841765	756002868	University	663573	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	OFFICE OF POST AWARD ADMINISTRATION
UNIVERSITY OF TEXAS MD ANDERSON
P O BOX 4390		HOUSTON	TX	772104390	746001118		293764	0	N/A	N/A	IMPROVING EARLY DETECTION OF BREAST CANCER WITH A BLOOD	GRANTS & CONTRACTS ACCOUNTING
UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE	RM 406	SALT LAKE CITY	UT	841129020	876000525	University	93134	0	N/A	N/A	PROSTAGLANDIN SYNTHESIS, GENETICS AND COLORECTAL CANCER	GRANTS & CONTRACTS ACCOUNTING
UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE	RM 406	SALT LAKE CITY	UT	841129020	876000525	University	52618	0	N/A	N/A	GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN C	GRANTS & CONTRACTS ACCOUNTING
UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE	RM 406	SALT LAKE CITY	UT	841129020	876000525	University	79474	0	N/A	N/A	THE TIME DISTRIBUTION METHOD FOR MEASURING CLINICALLY VA	GRANTS & CONTRACTS ACCOUNTING
UNIVERSITY OF VERMONT AND
P O BOX 1389		WILLISTON	VT	054951389	030179440	University	12820	0	N/A	N/A	A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	5224	0	N/A	N/A	VANGUARD CLINICAL CENTER FOR CLINICAL TRIAL & OBSERVATIO
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	23322	0	N/A	N/A	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	33210	0	N/A	N/A	ENHANCING LONG-TERM 5-A-DAY BEHAVIOR CHANGE IN WORKSITES
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	170869	0	N/A	N/A	REDUCING OBESITY AT THE WORKPLACE- A RANDOMIZED TRIAL
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	27032	0	N/A	N/A	HEPATITIS B ESL EDUCATION FOR CHINESE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	279158	0	N/A	N/A	THERAPY OF LYMPHOMA/LEUKEMIA WITH MONOCLONAL ANTIBODIES
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	10170	0	N/A	N/A	MODELING US PROSTATE CANCER TRENDS- PSA/ TREATMENT & RAC
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	175563	0	N/A	N/A	RADIATION DOSE-DEPENDENT INTERVENTIONS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	20101	0	N/A	N/A	CORE CENTER OF EXCELLENCE IN HEMATOLOGY
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	260501	0	N/A	N/A	TREC- MECHANISMS OF ENERGY BALANCE AND CANCER PREVENTION
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	46849	0	N/A	N/A	ASTATINE-211 CONDITIONING FOR NONMYELOABLATIVE HEMOPOIET
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	10690	0	N/A	N/A	THE ROLE OF UNCULTIVATED BACTERIA IN BACTERIAL VAGINOSIS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	5074474	0	N/A	N/A	HVTN LABORATORY PROGRAM
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	53229	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HVTN
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	271858	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HIV PR
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	167751	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- MICRO
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	2843022	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	39353	0	N/A	N/A	GENE THERAPY FOR FANCONI ANEMIA
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	93459	0	N/A	N/A	CORD BLOOD EXPANSION AND TRANSPLANTATION IN A NON-HUMAN
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	52541	0	N/A	N/A	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	105188	0	N/A	N/A	IN UTERO TRANSPLANTATION IN PRIMATES
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	9903	0	N/A	N/A	HEMATOPOIETIC CHEMOPROTECTION IN GLIOBLASTOMA PATIENTS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	58052	0	N/A	N/A	CORE ASSAYS MRLI - W1 W3
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	354034	0	N/A	N/A	SEATTLE VACCINE TRIALS UNIT
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	124618	0	N/A	N/A	LATE EFFECTS OF TREATMENT IN WILMS-TUMOR SURVIVORS AND O
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	5345	0	N/A	N/A	TGF-beta SIGNALING AND COLON CANCER
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	296333	0	N/A	N/A	CYTOTOXIC T CELL RESPONSE TO HSV IN HIV INFECTED PEOPLE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	37946	0	N/A	N/A	THE FANCONI ANEMIA-BRCA PATHWAY AND CHEMOSENSITIVITY OF
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	438532	0	N/A	N/A	IMMUNE CORRELATES OF PROTECTION AGAINST HIV AND SIV INFE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	6598	0	N/A	N/A	HPV- BIOLOGY, CLINICAL SIGNIFICANCE AND EPIDEMIOLOGY
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	14346	0	N/A	N/A	NIGHT SHIFT WORK AND HORMONE LEVELS IN MEN
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	45817	0	N/A	N/A	IMPROVING GASTROINTESTINAL RECOVERY AFTER RADIATION
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	14824	0	N/A	N/A	A MULTI-STATE STUDY OF CANCER TREATMENT AND OUTCOME AMON
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	118163	0	N/A	N/A	CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICA
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	269084	0	N/A	N/A	IMMUNOTHERAPY OF HEMATOLOGICAL MALIGNANCIES
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	747154	0	N/A	N/A	THE PACIFIC NORTHWEST PROSTATE CANCER SPORE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	147366	0	N/A	N/A	PRETARGETED RADIOIMMUNOTHERAPY OF CD20+ LYMPHOMAS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	102860	0	N/A	N/A	THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSI
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	45106	0	N/A	N/A	A PROSPECTIVE STUDY OF COLORECTAL CANCER- ONE-CARBON ME
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	17853	0	N/A	N/A	EVALUATION OF A HEPATITIS B OUTREACH INTERVENTION FOR CA
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	1837844	0	N/A	N/A	CLINICAL EPIDEMIOLOGY AND PATHOGENESIS OF ASYMPTOMATIC H
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	201405	0	N/A	N/A	FRED HUTCHINSON/UNIVERSITY OF WASHINGTON CANCER CONSORTI
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	28092	0	N/A	N/A	OUTCOMES BASED GUIDELINE DEVELOPMENT FOR PROSTATE CANCER
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	7716	0	N/A	N/A	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	1954635	0	N/A	N/A	CANCER CENTER SUPPORT GRANT (COMPREHENSIVE)
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	230773	0	N/A	N/A	MIXED HEMATOPOIETIC CHIMERISM AFTER STEM CELL ALLOGRAFTS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	72753	0	N/A	N/A	IN VIVO EFFECTS OF SULFORAPHANE SUPPLEMENTATION ON NORMA
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	69340	0	N/A	N/A	CD8+ CELL IMMUNITY TO CYTOMEGALOVIRUS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	126623	0	N/A	N/A	MITIGATION OF RADIATION-INDUCED LUNG INJURY IN THE DOG M
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	19193	0	N/A	N/A	WASHINGTON VACCINE ALLIANCE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	158660	0	N/A	N/A	CD45 PRETARGETED RADIOIMMUNOTHERAPY FOR AML
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	1309088	0	N/A	N/A	MECHANISMS AND COFACTORS OF HIV TRANSMISSION TO WOMEN
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	26099	0	N/A	N/A	NORTH AMERICAN SHWACHMAN-DIAMOND SYNDROME REGISTRY
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	226679	0	N/A	N/A	DEVELOPMENT OF NOVEL AIDS GENE THERAPY STRATEGIES IN THE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	8145	0	N/A	N/A	SCHWACHMAN-DIAMOND SYNDROME INTERNATIONAL REGISTRY AND R
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	851622	0	N/A	N/A	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	155909	0	N/A	N/A	INNATE RESISTANCE TO MUCOSAL HSV INFECTION IN HUMANS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	47623	0	N/A	N/A	ORAL CANCER- MOLECULAR PROFILES & CLINICAL OUTCOMES
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	209749	0	N/A	N/A	CHEMOPROTECTION AGAINST AMINOGLYCOSIDE-INDUCED OTOTOXICI
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	99879	0	N/A	N/A	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	293477	0	N/A	N/A	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	57389	0	N/A	N/A	PRECLINICAL GENE THERAPY STUDIES IN CANINE MUSCULAR DYST
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	29947	0	N/A	N/A	INFLAMMATORY DENDRITIC CELLS IN ADIPOSE TISSUE INFLAMMAT
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	234061	0	N/A	N/A	SEATTLE CANCER CONSORTIUM BREAST SPORE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	142177	0	N/A	N/A	DEVELOPMENT OF SAFE AND EFFICIENT GENE THERAPY STRATEGIE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	72981	0	N/A	N/A	HIV TESTING IN GENITAL TRACT SECRETIONS - MERCK SITES' S
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	29723	0	N/A	N/A	HPV CAPSID ANTIBODIES
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	439542	0	N/A	N/A	INTERGRATED SENSOR TECHNOLOGY FOR REAL-TIME RECORDING OF
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	48877	0	N/A	N/A	ANALYSIS OF A NOVEL SUBSET OF HUMAN CD8+ MEMORY CELLS WI
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	254771	0	N/A	N/A	CONTROLLING HEMATOPOIETIC LINEAGE COMMITMENT FROM ESC TO
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	564632	0	N/A	N/A	EXPANSION OF CARDIAC AND HEMATOPOIETIC PREGENITORS BY WN
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	307517	0	N/A	N/A	THE PATHOGENESIS OF FMD- FACIOSCAPULOHUMERAL MUSCULAR
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	167057	0	N/A	N/A	UNDERSTANDING AND PREVENTING BREAST CANCER DISPARITIES I
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	361601	0	N/A	N/A	CENTER FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CANCER
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	88292	0	N/A	N/A	ANALYZING HETEROGENEITY OF ONCOGENIC PATHWAY ACTIVATION
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	14408	0	N/A	N/A	MERCK AURORA KINASE A INHIBITOR STUDY (MK-5108)
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	60137	0	N/A	N/A	A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	42719	0	N/A	N/A	LATE EFFECTS OF TREATMENT IN WILMS TUMOR SURVIVORS AND O
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	100652	0	N/A	N/A	GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN C
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	202864	0	N/A	N/A	CONSORTIUM BIOSPECIMEN PROGRAM
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	196702	0	N/A	N/A	EARLY AND REINFECTION IN HIGH RISK WOMEN
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	59201	0	N/A	N/A	NOVEL CULTIVATION METHODS FOR THE DOMESTICATION OF VAGIN
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	144659	0	N/A	N/A	VIRAL PANELS DATABASE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	10744	0	N/A	N/A	IDENTIFY AND VALIDATE NOVEL EPIGENETIC MOLECULAR MARKERS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	24900	0	N/A	N/A	LYMPH NODE ALTERATIONS IN CANCER
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	149868	0	N/A	N/A	STRATEGIES TO IMPROVE THE ADOPTIVE TRANSFER OF T CELLS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	17110	0	N/A	N/A	NUTRITION AND PHYSICAL ACTIVITY ASSESSMENT STUDY (NPAAS)
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	68121	0	N/A	N/A	MODELING PROSTATE CANCER CONTROL- PREVENTION/ SCREENING
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	13412	0	N/A	N/A	ADIPOSE TISSUE INFLAMMATION AND ESTROGEN SYNTHESIS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	89979	0	N/A	N/A	STATISTICAL METHODS IN HIV/AIDS RESEARCH
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	58352	0	N/A	N/A	NOVEL COMPUTATIONAL TOOLS FOR STUDYING THE HUMAN MICROBI
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	156777	0	N/A	N/A	CANCER IMMUNOTHERAPY TRIALS NETWORK CENTRAL OPERATIONS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	40388	0	N/A	N/A	CORE CENTER OF EXCELLENCE IN HEMATOLOGY
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	68194	0	N/A	N/A	CORE CENTER OF EXCELLENCE IN HEMATOLOGY
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	149283	0	N/A	N/A	WASHINGTON VACCINE ALLIANCE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916001537	University	810196	0	N/A	N/A	FRED HUTCHINSON/UNIVERSITY OF WASHINGTON CANCER CONSORTI
UNIVERSITY OF WISCONSIN
DRAWER 538		MILWAUKEE	WI	532780538	396006492	University	7491	0	N/A	N/A	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT	OFFICE FOR RESEARCH and SPONSORED PROGRAMS
UNIVERSITY OF WISCONSIN
DRAWER 538		MILWAUKEE	WI	532780538	396006492	University	68304	0	N/A	N/A	NUTRITION AND PHYSICAL ACTIVITY ASSESSMENT STUDY (NPAAS)	OFFICE FOR RESEARCH and SPONSORED PROGRAMS
VACCINE & GENE THERAPY INSTITUTE FLORIDA
11350 SW VILLAGE PARKWAY	3RD FLOOR	PORT ST LUCIE	FL	34987	364631835	501(c)(3)	326756	0	N/A	N/A	HVTN LABORATORY PROGRAM
VANDERBILT UNIVERSITY
DEPT AT 40303		ATLANTA	GA	311920303	620476822	501(c)(3)	986374	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	DEPT OF FINANCE
VANDERBILT UNIVERSITY
DEPT AT 40303		ATLANTA	GA	311920303	620476822	501(c)(3)	25261	0	N/A	N/A	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD	DEPT OF FINANCE
VANDERBILT UNIVERSITY
2301 VANDERBILT PLACE	PMB 401591	NASHVILLE	TN	372401591	620476822	501(c)(3)	385191	0	N/A	N/A	TILLING THE ZEBRAFISH GENOME- A REVERSE GENETICS APPROAC
WAKE FOREST UNIVERSITY HEALTH SCIENCES
MEDICAL CENTER BOULEVARD		WINSTON SALEM	NC	27157	223849199	501(c)(3)	290404	0	N/A	N/A	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT	CONTROLLERS OFFICE
WASHINGTON STATE UNIVERSITY
P O BOX 641039		PULLMAN	WA	991641039	916001108	University	103346	0	N/A	N/A	ENGINEERING ENZYMES FOR ANTI-TUMOR SUICIDE GENE THERAPY	CASHIERS OFFICE
WASHINGTON STATE UNIVERSITY
P O BOX 641027	240 FRENCH ADMINSTRATION BLDG	PULLMAN	WA	991641027	916001108	University	205475	0	N/A	N/A	WASHINGTON VACCINE ALLIANCE	CASHIER'S OFFICE-SPS
WASHINGTON UNIVERSITY DBA
700 ROSEDALE AVENUE	CAMPUS BOX 1034	ST LOUIS	MO	631121408	430653611	501(c)(3)	83220	0	N/A	N/A	RADIATION DOSE-DEPENDENT INTERVENTIONS	SPONSORED PROJECTS ACCOUNTING
WASHINGTON UNIVERSITY DBA
660 SOUTH EUCLID AVE	CB8009	ST LOUIS	MO	631108009	430653611	501(c)(3)	5400	0	N/A	N/A	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD	ATTN WESTERVELT/TMP4172/944214
WEILL MEDICAL COLLEGE OF CORNELL UNIV
100 BROADWAY 8TH FLOOR		NEW YORK	NY	10005	131623978		10039	0	N/A	N/A	HVTN LABORATORY PROGRAM	RESEARCH ACCOUNTING DEPARTMENT
WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
3601 SPRUCE STREET		PHILADELPHIA	PA	19104	236434390	501(c)(3)	83241	0	N/A	N/A	BARRETT'S ESOPHAGUS- PREDICTORS OF PROGRESSION
YALE UNIVERSITY
P O BOX 1873		NEW HAVEN	CT	065081873	060646973	501(c)(3)	15977	0	N/A	N/A	TREC COORDINATION CENTER	GRANTS & CONTRACT FINANCIAL ADMIN
YALE UNIVERSITY
P O BOX 1873		NEW HAVEN	CT	065081873	060646973	501(c)(3)	73114	0	N/A	N/A	ADULT LEUKEMIA RESEARCH CENTER	GRANTS & CONTRACT FINANCIAL ADMIN
YALE UNIVERSITY
P O BOX 1873		NEW HAVEN	CT	065081873	060646973	501(c)(3)	8460	0	N/A	N/A	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI	GRANTS & CONTRACT FINANCIAL ADMIN
YESHIVA UNIVERSITY
1300 MORRIS PARK AVE	BELFER BLDG RM 1108	BRONX	NY	10461	131624225	501(c)(3)	8709	0	N/A	N/A	INNATE RESISTANCE TO MUCOSAL HSV INFECTION IN HUMANS	ALBERT EINSTEIN COLLEGE OF MEDICINE

Field	Value	IRS element (for citing)
Total Nbr Of501 C3 And Govt Grants	143	TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations	184	TotalNbrOfOtherOrganizations

Form990 Schedule I Part IV Form990ScheduleIPartIV

Field	Value	IRS element (for citing)
Identifier	SchI_P01_S00_L02	Identifier
Return Reference	Schedule I, Part I, Line 2	ReturnReference
Explanation	Schedule I, Part I, Line 2 - Procedures for Monitoring the Use of Grant Funds: Once the notice of award has been received and the Center project ID activated, the subaward can be set up. The structure of the subaward will depend on how the Prime is set up. Generally at the Center, a new purchase order (PO) is requisitioned for each subaward for each year of a project. This allows the Research Coordinator (RC) to closely monitor subaward invoices and encumbrances. For our Subrecipients, it means a separate budget ID and final invoice each year. Carryover between years is not automatic. There are 5 primary stems. 1) Step one is within Office of Sponsored Research (OSR). The Grant Specialist notifies the Contract Specialist that a grant which includes a subaward has been funded, and provides to the Contract Specialist a copy of the award, the signed subaward application (if available) and any special instructions. A signed subaward application is important because it shows that the Subrecipient organization has reviewed and approved the budget and scope of work. 2) The RC sends the Contract Specialist a Subcontract Acquisition Form (SAF). This form provides authorization for the Contract Specialist to issue the subaward, and includes a scope of work, budget, and pertinent subrecipient information. It is necessary to provide the scope of work and budget on the SAF as these items may have changed from what was originally submitted in the subaward application. 3) The Contract Specialist requisitions the subaward PO, which the RC must approve. An e-mail is sent to the RC notifying them that the requisition is pending and requires approval. Because OSR does not have funds commitment authority the RC is required to approve all requisitions. 4) OSR collects information required to correctly set up the subaward. These items include Institutional Review Office (IRO) and Institutional Animal Care and Use Committee (IACUC) approval dates, confirmation of subaward Facilities and Administrative (F&A) rates and A-133 Audit reports, review of Prime special terms and conditions to determine flow-down, confirmation that the Subrecipient is not debarred, and other similar regulatory and administrative requirements. While much of this information is collected by OSR, the RC may, in addition to completing the SAF, be asked to assist in the collection of some of the documentation. 5) OSR writes the subaward agreement, and mails it to the Subrecipient for signature. Some agreements can be signed by OSR before mailing, while others will be sent unsigned. This is determined by the Contract Specialist based on the term of award and status of administrative and regulatory requirements. A copy of the initial subaward is sent to the RC. Once the subaward has been fully signed, a copy is sent to the RC for their files. No invoices should be approved by the RC until they have received a fully executed agreement.	Explanation

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
First Class Or Charter Travel	X	FirstClassOrCharterTravel
Travel For Companions	X	TravelForCompanions
Club Dues Or Fees	X	ClubDuesOrFees
Written Policy Re T And E Expenses	1	WrittenPolicyReTAndEExpenses
Substantiation Required	1	SubstantiationRequired
Compensation Committee	X	CompensationCommittee
Independent Consultant	X	IndependentConsultant
Compensation Survey	X	CompensationSurvey
Board Or Committee Approval	X	BoardOrCommitteeApproval
Severance Payment	0	SeverancePayment
Supplemental Nonqual Retire Plan	0	SupplementalNonqualRetirePlan
Equity Based Comp Arrangement	0	EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org	0	CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs	0	CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org	0	CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs	0	CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments	0	AnyNonFixedPayments
Initial Contract Exception	0	InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (25 entries)

Base Compensation Filing OrgBaseCompensationFilingOrg	Comp Based On Related OrgsCompBasedOnRelatedOrgs	Bonus Filing OrgBonusFilingOrg	Bonus Related OrgsBonusRelatedOrgs	Other Compensation Filing OrgOtherCompensationFilingOrg	Other Compensation Related OrgsOtherCompensationRelatedOrgs	Deferred Comp Filing OrgDeferredCompFilingOrg	Deferred Comp Related OrgsDeferredCompRelatedOrgs	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg	Nontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgs	Total Compensation Filing OrgTotalCompensationFilingOrg	Total Compensation Related OrgsTotalCompensationRelatedOrgs	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrg	Comp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
Leland H Hartwell
468409	0	124481	0	0	0	0	0	41293	0	634183	0	0	0
Frederick R Appelbaum
519933	0	68421	0	0	0	0	0	43686	0	632040	0	0	0
Janell E Baldwin
182337	0	20000	0	0	0	0	0	32522	0	234859	0	0	0
Anthony Bozzuti
243506	0	12250	0	0	0	0	0	16074	0	271830	0	0	0
Jonathan Cooper
262763	0	0	0	0	0	0	0	38439	0	301202	0	0	0
Linda L Gainer
216720	0	30000	0	0	0	0	0	43292	0	290012	0	0	0
Mark T Groudine
319280	0	148900	0	0	0	16500	0	44556	0	529236	0	0	0
Randall C Main
328324	0	40000	0	0	0	0	0	44556	0	412880	0	0	0
Margaret Juliana McElrath
232458	0	0	0	0	0	14400	0	44791	0	291649	0	0	0
Ulrich W Mueller
222869	0	30000	0	0	0	0	0	47322	0	300191	0	0	0
Howard Albert Nachtrieb
212965	0	30000	0	0	0	0	0	47250	0	290215	0	0	0
Ross L Prentice
399255	0	0	0	0	0	0	0	44538	0	443793	0	0	0
Scott N Rusch
181776	0	20000	0	0	0	0	0	38218	0	239994	0	0	0
Douglas J Shaeffer
289538	0	30000	0	0	0	0	0	44807	0	364345	0	0	0
Myra H Tanita
398212	0	75000	0	0	0	6000	0	39780	0	518992	0	0	0
Barbara Trask
284882	0	0	0	0	0	16500	0	40278	0	341660	0	0	0
Steven G Self
281222	0	0	0	0	0	16500	0	51142	0	348864	0	0	0
F Marc Stewart
151503	0	45868	0	0	0	0	0	37179	0	234550	0	0	0
Rainier F Storb
247218	0	0	0	0	0	16500	0	40936	0	304654	0	0	0
James M Roberts
148155	0	0	0	0	0	0	0	35145	0	183300	0	0	0
Irwin D Bernstein
295080	0	0	0	0	0	16500	0	42665	0	354245	0	0	0
Martin A Cheever
288162	0	0	0	0	0	16500	0	40195	0	344857	0	0	0
Samir M Hanash
328794	0	0	0	0	0	0	0	43254	0	372048	0	0	0
Charles N Petty
262694	0	0	0	0	0	0	0	36995	0	299689	0	0	0
Henry F Warden
228116	0	33696	0	0	0	0	0	39064	0	300876	0	0	0

Form990 Schedule J Part III Form990ScheduleJPartIII

Field	Value	IRS element (for citing)
Identifier	SchJ_P01_S00_L01a	Identifier
Return Reference	Schedule J, Part I, Line 1a	ReturnReference
Explanation	First-class air travel is allowed consistent with federal reimbursement regulations and generally only when coach fare is not available. Airfare and normal travel expenses are paid for the President & Director's spouse for trips involving fundraising for the Center. Social club dues are paid for the Center's President & Director.	Explanation

Schedule K IRS990ScheduleK

Form990 Schedule K Part I Form990ScheduleKPartI (4 entries)

Issuer EINIssuerEIN	Date IssuedDateIssued	Issue PriceIssuePrice	Description Of PurposeDescriptionOfPurpose	DefeasedDefeased	On Behalf Of IssuerOnBehalfOfIssuer	Pool FinancingPoolFinancing	CUSIP NumberCUSIPNumber
Washington Health Care Facilities Authority
911108929	2007-11-15	5200000	See Part V.	0	0	0
Washington Health Care Facilities Authority
911108929	2009-11-24	15381009	Refund bonds issued 11/1/2002	0	0	0	93978E6G2
Washington Health Care Facilities Authority
911108929	2009-11-24	8842608	Refund bonds issued 11/1/2002	0	0	0	93978E6G2
Washington Health Care Facilities Authority
911108929	2009-11-24	32093411	Refund bonds issued 11/1/2002	0	0	0	93978E6G2

Form990 Schedule K Part II Form990ScheduleKPartII (4 entries)

Amount RetiredAmountRetired	Total ProceedsTotalProceeds	Amount In Reserve FundAmountInReserveFund	Issuance Costs From ProceedsIssuanceCostsFromProceeds	Working Capital ExpendituresWorkingCapitalExpenditures	Capital ExpendituresCapitalExpenditures	Year Of Subst CompletionYearOfSubstCompletion	Current RefundingCurrentRefunding	Final Allocation MadeFinalAllocationMade	Adequate Books And Recds MaintaindAdequateBooksAndRecdsMaintaind
425274	5200000	0	35948	32182	5131870	2007	0	1	1
454841	15381009	1466385	169304	69174	0	2009	1	1	1
261490	8842608	843031	97333	39769	0	2009	1	1	1
949053	32093411	3059701	353262	144336	0	2009	1	1	1

Form990 Schedule K Part III Form990ScheduleKPartIII (4 entries)

Bond Counsel Routinely EngagedBondCounselRoutinelyEngaged	Prcntge Prvt Business Use By OthersPrcntgePrvtBusinessUseByOthers	Percentage Of Prvt Business Re UBIPercentageOfPrvtBusinessReUBI	Post Issuance Compliance ProcdrsPostIssuanceComplianceProcdrs
1	0	0	1
1			1
1			1
1			1

Form990 Schedule K Part IV Form990ScheduleKPartIV (4 entries)

Form8038 T FiledForm8038TFiled	Variable Rate IssueVariableRateIssue	Hedge Identified In Books And RecdsHedgeIdentifiedInBooksAndRecds	Gross Proceeds Invested In GICGrossProceedsInvestedInGIC	Gross Proceeds InvestedGrossProceedsInvested	Exception To RebateExceptionToRebate
0	0	0	0	0	0
0	0	0	0	0	0
0	0	0	0	0	0
0	0	0	0	0	0

Form990 Schedule K Part V Form990ScheduleKPartV (3 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
SchK_P01_S00_L00	Schedule K, Part I	For the issue amount of $5,200,000 dated 11/15/2007, the description of purpose is to reimburse the Center for costs of acquiring real property and improvements and pay issuance costs.
SchK_P01_S00_L00c	Schedule K, Part I, Column c	No CUSIP available for $5,200,000 (DTD 11/15/2007) and $30,000,000 (DTD 11/04/2010).
SchK_P01_S00_L00f	Schedule K, Part I, Column f	For the CUSIP # 93978HBV6, bond issue amount of $84,147,349 dated 6/30/2011, the description of purpose is to repay a taxable bridge loan incurred by the Center to acquire land and the 1100 Eastlake Building in Seattle, Washington. To construct, remodel, renovate and equip health care facilities located at the 1100 Eastlake Building and at the Center's existing South Lake Union Campus in Seattle. To construct a connection between the 1100 Eastlake Building and the South Lake Union Campus.

Schedule K IRS990ScheduleK

Form990 Schedule K Part I Form990ScheduleKPartI (4 entries)

Issuer EINIssuerEIN	CUSIP NumberCUSIPNumber	Date IssuedDateIssued	Issue PriceIssuePrice	Description Of PurposeDescriptionOfPurpose	DefeasedDefeased	On Behalf Of IssuerOnBehalfOfIssuer	Pool FinancingPoolFinancing
Washington Health Care Facilities Authority
911108929	93978E6G2	2009-11-24	18735275	Refund bonds issued 11/1/2002	0	0	0
Washington Health Care Facilities Authority
911108929	93978E6G2	2009-11-24	39972686	Refund bonds issued 11/1/2002	0	0	0
Washington Health Care Facilities Authority
911108929		2010-11-04	30000000	Acquisition of a six-story office building	0	0	0
Washington Health Care Facilities Authority
911108929	93978HCL7	2011-06-30	49522564	Refund bonds issued 11/15/2001	0	0	0

Form990 Schedule K Part II Form990ScheduleKPartII (4 entries)

Amount RetiredAmountRetired	Total ProceedsTotalProceeds	Amount In Reserve FundAmountInReserveFund	Issuance Costs From ProceedsIssuanceCostsFromProceeds	Working Capital ExpendituresWorkingCapitalExpenditures	Capital ExpendituresCapitalExpenditures	Amount UnspentAmountUnspent	Year Of Subst CompletionYearOfSubstCompletion	Current RefundingCurrentRefunding	Final Allocation MadeFinalAllocationMade	Adequate Books And Recds MaintaindAdequateBooksAndRecdsMaintaind
554031	18735275	1786172	206225	84260	0	0	2009	1	1	1
220585	39972686	3829025	627017	0	0	0	2009	1	1	1
0	30000000	0	367238	0	29216470	416292	2010	0	0	1
0	49522564	0	533360	0	0	142632	2011	1	0	1

Form990 Schedule K Part III Form990ScheduleKPartIII (4 entries)

Mngment Cntrct Bond Financd PrprtyMngmentCntrctBondFinancdPrprty	Bond Counsel Routinely EngagedBondCounselRoutinelyEngaged	Total Private Business UseTotalPrivateBusinessUse	Post Issuance Compliance ProcdrsPostIssuanceComplianceProcdrs	Prcntge Prvt Business Use By OthersPrcntgePrvtBusinessUseByOthers	Percentage Of Prvt Business Re UBIPercentageOfPrvtBusinessReUBI
0	1	0	1
0	1	0	1
1	1	0.005	1	0.005	0
0	1	0	1

Form990 Schedule K Part IV Form990ScheduleKPartIV (4 entries)

Form8038 T FiledForm8038TFiled	Variable Rate IssueVariableRateIssue	Hedge Identified In Books And RecdsHedgeIdentifiedInBooksAndRecds	Gross Proceeds Invested In GICGrossProceedsInvestedInGIC	Gross Proceeds InvestedGrossProceedsInvested	Exception To RebateExceptionToRebate
0	0	0	0	0	0
0	0	0	0	0	0
0	1	0	0	0	0
0	0	0	0	0	0

Schedule K IRS990ScheduleK

Form990 Schedule K Part I Form990ScheduleKPartI (4 entries)

Issuer EINIssuerEIN	CUSIP NumberCUSIPNumber	Date IssuedDateIssued	Issue PriceIssuePrice	Description Of PurposeDescriptionOfPurpose	DefeasedDefeased	On Behalf Of IssuerOnBehalfOfIssuer	Pool FinancingPoolFinancing
Washington Health Care Facilities Authority
911108929	93978HCL7	2011-06-30	33478278	Refund bonds issued 11/24/2009	0	0	0
Washington Health Care Facilities Authority
911108929	93978HBT1	2011-06-30	34532776	Refund bonds issued 11/15/2001	0	0	0
Washington Health Care Facilities Authority
911108929	93978HBT1	2011-06-30	17411441	Refund bonds issued 11/24/2009	0	0	0
Washington Health Care Facilities Authority
911108929	93978HBT1	2011-06-30	5580783	Refund bonds issued 11/24/2009	0	0	0

Form990 Schedule K Part II Form990ScheduleKPartII (4 entries)

Total ProceedsTotalProceeds	Issuance Costs From ProceedsIssuanceCostsFromProceeds	Amount UnspentAmountUnspent	Year Of Subst CompletionYearOfSubstCompletion	Current RefundingCurrentRefunding	Adequate Books And Recds MaintaindAdequateBooksAndRecdsMaintaind
33478278	360562	96422	2011	1	1
34532776	188417	375670	2011	1	1
17411441	95000	189413	2011	1	1
5580783	30450	60711	2011	1	1

Form990 Schedule K Part III Form990ScheduleKPartIII (4 entries)

Owning Bond Financed PropertyOwningBondFinancedProperty	Any Lease ArrangementsAnyLeaseArrangements	Mngment Cntrct Bond Financd PrprtyMngmentCntrctBondFinancdPrprty	Any Research AgreementsAnyResearchAgreements	Bond Counsel Routinely EngagedBondCounselRoutinelyEngaged	Total Private Business UseTotalPrivateBusinessUse	Post Issuance Compliance ProcdrsPostIssuanceComplianceProcdrs
0	0	0	0	1	0	1
0	0	0	0	1	0	1
0	0	0	0	1	0	1
0	0	0	0	1	0	1

Form990 Schedule K Part IV Form990ScheduleKPartIV (4 entries)

Form8038 T FiledForm8038TFiled	Variable Rate IssueVariableRateIssue	Hedge Identified In Books And RecdsHedgeIdentifiedInBooksAndRecds	Gross Proceeds Invested In GICGrossProceedsInvestedInGIC	Gross Proceeds InvestedGrossProceedsInvested	Exception To RebateExceptionToRebate	Term Of HedgeTermOfHedge	Superintegrated HedgeSuperintegratedHedge	Hedge TerminatedHedgeTerminated
(no name)
0	0	0	0	0	0
Barclays Bank PLC
0	1	1	0	0	0	17.5	0	0
Barclays Bank PLC
0	1	1	0	0	0	17.5	0	0
Barclays Bank PLC
0	1	1	0	0	0	17.5	0	0

Schedule K IRS990ScheduleK

Form990 Schedule K Part I Form990ScheduleKPartI (2 entries)

Issuer EINIssuerEIN	CUSIP NumberCUSIPNumber	Date IssuedDateIssued	Issue PriceIssuePrice	Description Of PurposeDescriptionOfPurpose	DefeasedDefeased	On Behalf Of IssuerOnBehalfOfIssuer	Pool FinancingPoolFinancing
Washington Health Care Facilities Authority
911108929	93978HBV6	2011-06-30	352651	Refund bonds issued 11/24/2009	0	0	0
Washington Health Care Facilities Authority
911108929	93978HBV6	2011-06-30	84147349	See Part V.	0	0	0

Form990 Schedule K Part II Form990ScheduleKPartII (2 entries)

Amount RetiredAmountRetired	Amount Bond DefeasedAmountBondDefeased	Total ProceedsTotalProceeds	Amount In Reserve FundAmountInReserveFund	Capitalized InterestCapitalizedInterest	Refunding EscrowRefundingEscrow	Issuance Costs From ProceedsIssuanceCostsFromProceeds	Credit EnhancementCreditEnhancement	Working Capital ExpendituresWorkingCapitalExpenditures	Capital ExpendituresCapitalExpenditures	Other Spent ProceedsOtherSpentProceeds	Amount UnspentAmountUnspent	Year Of Subst CompletionYearOfSubstCompletion	Current RefundingCurrentRefunding	Advance RefundingAdvanceRefunding	Final Allocation MadeFinalAllocationMade	Adequate Books And Recds MaintaindAdequateBooksAndRecdsMaintaind
0	0	352651	0	0	0	847	927	0	0	0	3990	2011	1	0	0	1
0	0	84147349	0	0	0	202019	221089	0	37037809	0	46686432		0	0	0	1

Form990 Schedule K Part III Form990ScheduleKPartIII (2 entries)

Owning Bond Financed PropertyOwningBondFinancedProperty	Any Lease ArrangementsAnyLeaseArrangements	Mngment Cntrct Bond Financd PrprtyMngmentCntrctBondFinancdPrprty	Any Research AgreementsAnyResearchAgreements	Bond Counsel Routinely EngagedBondCounselRoutinelyEngaged	Total Private Business UseTotalPrivateBusinessUse	Post Issuance Compliance ProcdrsPostIssuanceComplianceProcdrs	Prcntge Prvt Business Use By OthersPrcntgePrvtBusinessUseByOthers	Percentage Of Prvt Business Re UBIPercentageOfPrvtBusinessReUBI
0	0	0	0	1	0	1
0	0	0	0	1	0	1	0	0

Form990 Schedule K Part IV Form990ScheduleKPartIV (2 entries)

Form8038 T FiledForm8038TFiled	Variable Rate IssueVariableRateIssue	Hedge Identified In Books And RecdsHedgeIdentifiedInBooksAndRecds	Term Of HedgeTermOfHedge	Superintegrated HedgeSuperintegratedHedge	Hedge TerminatedHedgeTerminated	Gross Proceeds Invested In GICGrossProceedsInvestedInGIC	Gross Proceeds InvestedGrossProceedsInvested	Exception To RebateExceptionToRebate
Barclays Bank PLC
0	1	1	20.5	0	0	0	0	0
Barclays Bank PLC
0	1	1	20.5	0	0	0	0	0

Schedule L IRS990ScheduleL

Form990 Schedule L Part IV Form990ScheduleLPartIV (4 entries)

RelationshipRelationship	Amount Of TransactionAmountOfTransaction	Description Of TransactionDescriptionOfTransaction	Sharing Of RevenuesSharingOfRevenues
Jean McDougall
See Part V.	14210	See Part V.	0
Becton Dickenson
See Part V.	2667109	See Part V.	0
Becton Dickenson
See Part V.	1910003	See Part V.	0
Ikaria
See Part V.	512264	See Part V.	0

Form990 Schedule L Part V Form990ScheduleLPartV

Field	Value	IRS element (for citing)
Identifier	SchL_P04_S00_L00	Identifier
Return Reference	Schedule L, Part IV	ReturnReference
Explanation	1(a) Jean McDougall; (b) Daughter of Officer; (d) Compensation paid to interested person. 2(a) Becton Dickenson; (b) The spouse of B. Trask, who was an officer of the organization; (d) Research support received from interested person. 3(a) Becton Dickenson; (b) The spouse of B. Trask, who was an officer of the organization; (d) Medical supplies purchased from interested person. 4(a) Ikaria, (b) R. Nelson, organization trustee is a director of Ikaria; (d) Research support received from interested person.	Explanation

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTraded

Field	Value	IRS element (for citing)
Non Cash Checkbox	X	NonCashCheckbox
Number Of Contributions	56	NumberOfContributions
Noncash Contribs Rptd F990	6408528	NoncashContribsRptdF990
Method Of Determining Revenues	Market Value	MethodOfDeterminingRevenues

Other Non Cash Contributions Table OtherNonCashContributionsTable (2 entries)

Non Cash CheckboxNonCashCheckbox	DescriptionDescription	Number Of ContributionsNumberOfContributions	Noncash Contribs Rptd F990NoncashContribsRptdF990	Method Of Determining RevenuesMethodOfDeterminingRevenues
X	Equipment	1	33300	Market Value
X	Freight Delivery	1	330	Market Value

Field	Value	IRS element (for citing)
Any Property That Must Be Held	0	AnyPropertyThatMustBeHeld
Review Process Unusual NC Gifts	0	ReviewProcessUnusualNCGifts
Third Parties Used	1	ThirdPartiesUsed

Form990 Schedule M Part II Form990ScheduleMPartII (2 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
SchM_P01_S00_L00	Schedule M, Part I	Column (b): Organization is reporting the number of contributions.
SchM_P01_S00_L32b	Schedule M, Part I, Line 32b	The Center employs KMS Financial Services to sell securities received as contributions.

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (6 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
F990_P06_S0B_L00	Form 990, Part VI, Section B	Line 11A - Under the Center's bylaws, the Finance Committee is responsible for reviewing and investigating financial transactions of FHCRC including responsibility of internal and external auditing and for making recommendations to the Board concerning these matters. FHCRC's Vice President of Finance & Chief Financial Officer and his staff work closely with the outside accounting firm FHCRC engages to review the Form 990. The draft of the Form 990 is also reviewed by the Corporate Treasurer, the Executive Vice President & Chief Operating Officer and the Vice President & General Counsel prior to providing it to the Finance Committee. The Finance Committee consults with the Chief Operating Officer, Chief Financial Officer, General Counsel and Corporate Treasurer and such other persons as the Finance Committee may designate to review the draft Form 990. Subsequent to its review, the Finance Committee reports to the Board regarding its oversight of the Form 990. The final draft is provided to the full Board prior to filing the return.
F990_P06_S0B_L11b	Form 990, Part VI, Section B, Line 11b	The final draft is provided to the full Board prior to filing the return.
F990_P06_S0B_L12c	Form 990, Part VI, Section B, Line 12c	The Executive Committee of the Board is responsible for monitoring conflicts of interest involving trustees or the president & Director of the Center. The President & Director of the Center is responsible for monitoring conflict of interest involving other officers, scientific staff and other key personnel designated by the President & Director. Under the FHCRC Conflict of Interest Policy and the related Guidelines, an annual conflict of interest disclosure document aimed at determining family and business relationships and transactions that constitute a conflict of interest under the policy, is distributed to and must be completed by all covered persons. Dislosures by trustees and the President & Director are reviewed by the Office of the General Counsel who reports any conflicts to the Executive Committee with recommendations on appropriate terms for a conflict management plan. Conflict management plans for trustees ot the President & Director are reviewed and approved by the Executive Committee and signed by the person with the conflict of interest and the Chair of the Board. Disclosure by members of the scientific staff, officers other than the President & Director and other key personnel designated by the President & Director are reviewed by the Office of the President & Dierctor, the Office of the General Counsel, and the Director of the division in which the person has his or her primary appointment or responsibilities. If a conflict is determined to exist under the policy a written conflict management plan is recommended by the Office of the General Counsel and approved and signed by the Office of the Director, the Office of the General Counsel and the Division Director as well as the person who has the conflict. Conflict management plans are designated to manage, reduce or eliminate conflicts to prevent bias, improper influence, or misuse of FHCRC or government resources. The conflict management plans for trustees usually require the affected trustee to recuse himself or herself from voting on any matters involving the affected transaction or relationship although he or she is allowed to provide factual information if requested by the Board of Executive COmmittee. All transactions requiring Board or committee approval must be approved by a majority of disinterested persons. Conflict management plans involving scientific staff, officer or other key personnel usually impose one of more of the following conditions or restrictions: i) publid disclosure of the interest; ii) monitoring of research by independent reviewers; iii) modification of the research plan; iv) disqualification from participation in all of or a portion of the research by the person with the conflict of interest; v) divesture of the interest; vi) severance of the relationship creating the conflict of interest.
F990_P06_S0B_L15	Form 990, Part VI, Section B, Line 15	Compemsation for the President & Director is determined and approved by the Board Compensation Committee. The compensation of other officers and key personnel at FHCRC is determined by the President & Director subject to ratification by the Compensation Committee. The Compensation Committee has developed, consistent with the organization's philosophy and principles, guidelines for determining compensation and benefits. The Compensation Committee also hires a qualified independent compensation specialist ("independent expert") to review, analyze and provide benchmarking data for the total compensation packages of all officers and key employees. Appropriate comparability data is obtained from the independent expert. No person with a conflict of interest may participate in determining or approving any executive compensation. Meetings of the Compensation Committee are documented in minutes which are approved at the next committee meeting. The above process was last undertaken in 2010 and updated in 2011 for the following positions: Sr VP & Dir, Clin Res Div; VP Shared Resources; Sr VP & Dir, Basic Sci; Sr VP & Co-Dir, VIDD; VP External Affairs & Comm; Sr VP & Deputy Dir, FHCRC; President & Director; VP & Chief Financial Officer; VP Industry Rel & Tech Transfer; VP Human Resources; Sr VP & Dir, PHS; VP Information Technology; Sr VP & Dir, Basic Sci; VP Operations & Facilities; VP General Counsel; Exec VP & COO; Sr VP & Dir, Human Biology; and VP & Dir, Development.
F990_P06_S0C_L19	Form 990, Part VI, Section C, Line 19	While federal tax laws do not mandate that the organization's governing documents, Conflict of Interest Policy and financial statements be made available for public inspection, the organization makes these documents available upon request.
F990_P11_S00_L05	Form 990, Part XI, Line 5	$10,316,186 = Change in net unrealized gains and losses in fair value of investment; $2,816,994 = Change in value of split-interest agreements; $2,494,930 = Change in net unrealized fair value of swap instruments. Total is $15,628,110.

Schedule R IRS990ScheduleR

Form990 Schedule R Part II Form990ScheduleRPartII (2 entries)

Address Line1AddressUS/AddressLine1	CityAddressUS/City	StateAddressUS/State	ZIP CodeAddressUS/ZIPCode	EINEIN	Primary ActivitiesPrimaryActivities	Legal Domicile StateLegalDomicileState	Exempt Code SectionExemptCodeSection	Public Charity StatusPublicCharityStatus	Direct Controlling Entity NADirectControllingEntityNA	Address Line1AddressForeign/AddressLine1	CityAddressForeign/City	CountryAddressForeign/Country	Legal Domicile Foreign CountryLegalDomicileForeignCountry	Business Name Line1DirectControllingEntityName/BusinessNameLine1
Seattle Vaccine Research Fund
1100 Fairview Ave North	Seattle	WA	98109	331111221	See Part VII.	WA	501(c)(3)	11a	N/A
UPCID Ltd
					See Part VII		See Part VII	N/A		Upper Mulago Hill Road	Kampala	UG	UG	See Part VII

Field	Value	IRS element (for citing)
Receipt Of Int Ann Rents Royalties	0	ReceiptOfIntAnnRentsRoyalties
Gift Grant Or Cap Contr To Other Org	1	GiftGrantOrCapContrToOtherOrg
Gift Grant Or Cap Contr Fr Other Org	0	GiftGrantOrCapContrFrOtherOrg
Loans Or Guarantees To Other Org	0	LoansOrGuaranteesToOtherOrg
Loans Or Guarantees From Other Org	0	LoansOrGuaranteesFromOtherOrg
Sale Of Assets To Other Org	0	SaleOfAssetsToOtherOrg
Purchase Of Assets From Other Org	0	PurchaseOfAssetsFromOtherOrg
Exchange Of Assets	0	ExchangeOfAssets
Rental Of Facilities To Other Orgs	0	RentalOfFacilitiesToOtherOrgs
Rental Of Facilities Fr Other Orgs	0	RentalOfFacilitiesFrOtherOrgs
Perform Of Services For Other Orgs	0	PerformOfServicesForOtherOrgs
Perform Of Services By Other Orgs	0	PerformOfServicesByOtherOrgs
Sharing Of Facilities	0	SharingOfFacilities
Sharing Of Paid Employees	1	SharingOfPaidEmployees
Reimbursement Paid To Other Org	0	ReimbursementPaidToOtherOrg
Reimbursement Paid By Other Org	0	ReimbursementPaidByOtherOrg
Other Transfer To Other Org	0	OtherTransferToOtherOrg
Other Transfer From Other Org	0	OtherTransferFromOtherOrg

Transactions Related Orgs Table TransactionsRelatedOrgsTable (2 entries)

Transaction TypeTransactionType	Amount InvolvedAmountInvolved	Method Of Amt DeterminationMethodOfAmtDetermination
UPCID Ltd
b	359000	Cash Transaction
UPCID Ltd
n	54000	Cash Transaction

Form990 Schedule R Part VII Form990ScheduleRPartVII

Field	Value	IRS element (for citing)
Identifier	SchR_P02_S00_L00	Identifier
Return Reference	Schedule R, Part II	ReturnReference
Explanation	Primary activity of Seattle Vaccine Research Fund: Anti-retrovital therapy for eligible participants. Address of UPCID: c/o Uganda Cancer Institute, POB 3935, Mulago Hospital, Upper Mulago Hill Road, Kampala, Uganda. Primary activity of UPCID, Ltd: Research and education regarding cancer and infectious diseases. Exempt Code section for UPCID, Ltd: Uganda Income Tax Act CAP 340, Section 2(bb). Direct controlling entity for UPCID, Ltd: Fred Hutchinson Cancer Research Center.	Explanation